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Abstract 
 
As the incidence of obesity rises globally, it has become increasingly imperative 
to identify the mechanisms that cause obesity-related metabolic disease. In 
particular, oxidative stress in the adipose tissue is known to cause metabolic 
dysfunction, but the mechanisms that contribute to this process remain unclear. 
 
Protein carbonylation refers to the post-translational modification of lysine, 
cysteine, and histidine residues by diffusible electrophilic lipids. Specifically, 4- 
hydroxy-2-nonenal (4-HNE) and 4-hydroxy-2-hexenal (4-HHE) are produced at 
high levels in obese adipose tissue as a direct result of increased oxidative 
stress.  The studies herein focus on the hypothesis that protein carbonylation is a 
mechanistic link between elevated oxidative stress and metabolic dysfunction in 
obese adipose tissue. 
 
We found that protein carbonylation is elevated specifically in the nucleus of 
adipocytes as a consequence of obesity and of aging. Proteomic evaluation of 
these modifications revealed that the core histones and zinc finger proteins are 
major targets of carbonylation. Since these proteins are critical regulators of 
transcriptional mechanisms, these data describe a potential link between 
oxidative stress and altered expression of metabolic pathways in adipose tissue. 
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Introduction 
Dramatic increases in obesity and associated metabolic disease in modern 
culture have spurred great interest in defining molecular mechanisms underlying 
obesity-induced metabolic syndrome.  While decades of work have contributed to 
a general model of obesity-induced insulin resistance, there remain many open 
questions in the field.  Importantly, a primary goal both from a basic science 
perspective as well as from a clinical point of view is to identify the initiating 
factors that drive metabolic dysfunction in the obese state.   
 
At the molecular level, obesity-linked metabolic disease can be described as a 
chronic low-grade pro-inflammatory state in which immune cell-derived cytokines 
such as tumor necrosis factor alpha (TNF-α), interleukin 1 beta (IL-1β), 
interleukin 6 (IL-6) and interferon gamma (IFNγ) initiate a cascade of molecular 
events in adipocytes leading to increased oxidative stress, impaired 
mitochondrial function and endoplasmic reticulum (ER) stress that alter adipokine 
secretion and result in local and systemic insulin resistance.  However, despite 
advances in this mechanistic understanding, the molecular pathways that 
connect oxidative stress to mitochondrial dysfunction and ER stress remain 
unclear. Oxidative protein damage via carbonylation, particularly in the 
mitochondrion, represents an attractive mechanistic target behind this process 
and has garnered much attention over the last decade.   
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Protein carbonylation refers to oxidative protein damage that results from post-
translational modification of proteins with reactive lipid aldehydes such as 4-
hydroxy trans 2,3 nonenal (4-HNE), 4-hydroxy trans 2,3 hexenal (4-HHE), and 4-
oxo trans 2,3 nonenal (4-ONE).  Lipid aldehydes are formed at high levels under 
conditions of increased oxidative stress and as such, protein carbonylation has 
long been considered a biomarker of oxidative stress in adipocytes, neurons, and 
muscle cells.  It is now appreciated that protein carbonylation plays a major role 
in a wide array of cellular processes including the oxidative stress response, 
apoptosis, mitochondrial function, and cell proliferation1.  Moreover, numerous 
studies suggest that protein carbonylation may serve as an initiating factor that 
contributes to the development of various metabolic disease states including 
neurodegeneration, aging, and insulin resistance2-6. 
 
Protein carbonylation is acutely relevant to the field of adipose biology for 
oxidative stress is a major effector of metabolic disease in the obese state in 
humans and can be studied readily in a number of mouse and cell-based 
systems7,8.  Furthermore, the adipocyte contains very high levels of fatty acyl 
groups in the form of triacylglycerol, making the fat droplet a rich potential source 
for aldehyde synthesis, a quality that renders adipose tissue particularly 
susceptible to lipid oxidation and protein carbonylation.  Herein we describe 
oxidative stress in adipose tissue, its linkage to protein carbonylation, the current 
methods used to detect and analyze carbonylated proteins as well as provide a 
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comprehensive evaluation of known proteins and pathways that are targets of 
these modifications in adipose biology. 
 
Reactive Oxygen Species (ROS) 
Classically, oxidative stress is defined as an imbalance between the production 
of oxidants and the presence and activity of the antioxidant defense system.  
Although the term oxidative stress encompasses many forms of reactive 
oxidants, the production and signaling mechanisms of reactive oxygen species 
are the best characterized and will be the focus of this chapter7,9.  
 
Within the cellular environment three main reactive oxygen species dominate: 
superoxide anion (O2-), hydrogen peroxide (H2O2) and the hydroxyl radical 
(OH).  All ROS forms are generated under basal conditions as products of 
various metabolic functions within the cell.  Due to their high reactivity, each ROS 
is capable of non-enzymatically modifying proteins, DNA, RNA, carbohydrates 
and lipids in their biological environment.  This quality enables them to act as 
signaling molecules in metabolic pathways, and in fact, modest production of 
ROS is required for many cellular functions, including adipogensis1,10-12.  The 
high reactivity of these species also renders them toxic to the cell at high levels. 
As such, the production and metabolism of ROS is tightly controlled by 
antioxidant enzymes whose role is to reduce the pool of ROS such that oxidative 
damage to cellular machinery is minimized.   
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There are several metabolic systems that produce ROS as a consequence of 
normal enzymatic function. For example, xanthine oxidase, lipoxygenases, 
cyclooxygenases, nitric oxide synthases and the NADPH oxidase have all been 
shown to catalyze ROS production13. Beyond individual ROS-producing 
enzymes, the mitochondria contribute greatly to ROS pools, particularly under 
diseased states and in response to inflammatory stimuli.  Strikingly, there are 
eight known enzymes of ROS production within the mitochondria alone14,15.    
 
Within the mitochondria, electron leak from the electron transport chain is the 
most well studied source of ROS.  Under physiological conditions NADH and 
FADH2 oxidation by Complex’s I and II, respectively, liberate electrons that are 
passed between numerous carriers, releasing energy that is used to pump 
protons into the inter-mitochondrial membrane space.  The electrochemical 
potential created by the proton gradient is then utilized by the FoF1 ATP 
synthase, coupling its energy release to the formation of ATP.  However, 
compared to cardiac or skeletal muscle, adipocytes have very little work function 
and thus maintain high levels of ATP mostly for triacylglycerol synthesis.  
Moreover, under conditions where ATP levels are high and NADH oxidation is 
needed for glucose metabolism to facilitate triacylglycerol synthesis, electrons 
can leak from the electron transport chain (ETC), most likely at Complexes I and 
III, to form superoxide anion.   
  6 
 
The one electron reduction of molecular oxygen occurs virtually instantaneously 
as electrons leak from the electron transport chain.  Due to the unpaired electron, 
superoxide anion is unable to pass through lipid membranes and a result, if not 
enzymatically detoxified, will react and modify biomolecules in its immediate 
environment.  To prevent accumulation of superoxide anion, the mitochondria 
contain high levels of superoxide dismutase (SOD) for production of hydrogen 
peroxide (Figure 1).   
 
Hydrogen peroxide (H2O2) is the least reactive but most stable of the three major 
ROS forms. Due to its chemical nature, hydrogen peroxide is capable of both 
transmembrane diffusion as well as facilitated movement through aquaporins16,17. 
As such, its diffusibility allows it to traverse multiple compartments within the cell 
and interact with a wide variety of biomolecules distal from its site of formation.  
Thus, unlike superoxide anion that reacts within its immediate environment, the 
combined qualities of stability and diffusibility allow for a much broader functional 
boundary for H2O2.  
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Figure 1.  Metabolism of ROS and outcomes of oxidative stress. Superoxide 
is metabolized via SOD to yield hydrogen peroxide that is subsequently  
detoxified by PRDX, GPX or Catalase.  Alternatively, hydrogen peroxide can 
undergo Fenton chemistry forming hydroxyl radicals leading to the production of 
reactive lipid aldehydes. Upon formation, reactive aldehydes can either undergo 
detoxification by Phase I and Phase II enzymes or can covalently modify protein 
side chains (Lys, His, Cys) leading to protein carbonylation.   
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In general, H2O2 follows one of three paths in the adipocyte: detoxification by 
antioxidant enzymes, direct oxidation of biomolecules, or generation of the 
hydroxyl radical. There are many enzymes that metabolize hydrogen peroxide to 
water and molecular oxygen including peroxidredoxin, glutathione peroxidase 
and catalase (Figure 1)18.   These enzymes are present at high levels in the 
mitochondrion, but are also found throughout other cellular compartments and 
function to regulate the pool of H2O2 to prevent it from reaching toxic levels.  If 
H2O2 is not metabolized by antioxidants, it can oxidize a variety of targets and 
even at low levels is capable of oxidizing sulfur atoms of either cysteine or 
methionine, thereby altering protein function and affecting signaling pathways.   
 
Alternatively, in cells with high levels of H2O2 (potentiated by superoxide 
dismutase) and a diminished capacity for its metabolism (attenuated glutathione 
peroxidase, peroxiredoxin), free Fe+2 can readily oxidize hydrogen peroxide to 
the hydroxyl radical through Fenton chemistry19. The hydroxyl radical is the most 
reactive ROS. Unlike superoxide anion and H2O2, it is not readily metabolized 
and is only consumed through the removal of hydrogen atoms from molecules in 
its immediate environment, resulting in propagation of radical formation through 
oxidation of neighboring biomolecules.  In adipocytes, one common substrate for 
radical attack is the fatty acyl groups of membrane phospholipid or triacylglycerol.  
It is this mechanism that links hydroxyl radical formation to the production of lipid 
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aldehydes and therefore protein carbonylation (Figure 1).  Once oxidized, such 
lipids undergo bond rearrangement that can capture further radicals allowing for 
chain propagation. Secondary oxidation products of fatty acids followed by Hock 
cleavage can lead to a number of aldehydic products, including malondialdehyde 
(MDA), straight chain aldehydes and α,β-unsaturated aldehydes such as 4-HNE, 
4-ONE, acrolein and 4-HHE (Figure  2).  
  
The formation of specific α,β-unsaturated aldehyde species is dependent on the 
fatty acid composition of membrane phospholipids or triacylglycerol.  The length 
of the fatty acid can play a role, but more importantly in determining the species 
of aldehyde produced is the degree and location of unsaturation of the fatty acyl 
unit.  As such, 4-HNE and 4-ONE can be formed from n-6 poly-unsaturated fatty 
acids (PUFAs) such as arachidonic acid (AA) (20:4; n-6) or linoleic acid (18:2; n-
6) 20. This is in contrast 4-HHE, which can be formed from n-3 PUFAs such as 
docosahexaenoic acid (DHA) (22:6; n-3) and α-linolenic acid (18:3; n-3) (Figure 
2)20.  Adipose triacylglycerol is rich in polyunsaturated fatty acids and is therefore 
a likely site for aldehyde synthesis. Tissues with high levels of DHA and other n-3 
PUFAs, like in the brain, can be expected to produce increased levels of 4-HHE 
compared to 4-HNE/4-ONE21-24. Both subcutaneous as well as visceral adipose 
depots exhibit high levels of n-6 PUFAs and thus can be predicted to produce 
more 4-HNE/4-ONE25-27. This is exemplified by the observation that in murine 
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liver, levels of 4-HHE are around ~1500 ng/g tissue and 4-HNE levels are 
adipose tissue free HNE levels are ~100ng/g and free HHE is undetectable28.       
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Figure 2. Mechanism of formation of reactive α,β-unsaturated aldehydes 
from PUFA. Formation mechanism of A) 4-HNE from arachidonic acid (AA) and 
B) 4-HHE from docosahexaenoic acid (DHA). 
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Metabolism of Reactive Lipid Aldehydes 
In addition to the multiple enzymes expressed by the adipocyte that metabolize 
and detoxify ROS (O2- and H2O2) before they can cause oxidative damage to 
biomolecules, the cell is also equipped with enzymes that can reduce or mitigate 
damage to lipids and proteins after it takes place.  In particular, the enzymes 
responsible for the detoxification of reactive lipid aldehydes are of central 
importance in the adipocyte because this cell type houses large amounts of lipid 
and thus is particularly susceptible to oxidative damage to lipids under conditions 
of oxidative stress. Detoxification is achieved via several antioxidant pathways 
that either enzymatically decrease the reactivity of the lipid (phase I metabolism) 
or conjugate the lipid to glutathione, allowing for further modification and 
subsequent export from the cell (phase II metabolism).  Here we will consider the 
specific pathways that are involved in 4-HNE metabolism, as this is the most 
abundant lipid aldehyde in the adipocyte. 
 
During phase I metabolism, several key enzymes catalyze oxidation and 
reduction reactions that primarily serve to reduce the reactivity around carbon 3 
of the lipid.  These reactions are appropriately heralded as detoxification 
reactions because they yield lipid products that are orders of magnitude less 
reactive towards proteins, nucleic acids, and lipids. In general, phase I 
metabolism of reactive lipid aldehydes reduces the susceptibility of the lipid to 
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Michael addition, therefore protecting the cell against oxidative damage by 
protein carbonylation29. In adipose tissue, aldehyde dehydrogenase (ALDH), 
aldo-keto reductase (AKR), and alkenal/one oxidoreductase (AO) are the primary 
enzymes that are responsible for phase I metabolism of 4-HNE (Figure 1)29.    
 
In contrast to phase I metabolism which decreases the reactivity of the lipid, 
phase II metabolism prevents any possibility for the lipid to undergo Michael 
addition by conjugating glutathione to the lipid at the C3 carbon30. This reaction is 
primarily carried out by glutathione S-transferases (GSTs) subtype A3 or A4.  
GSTA4 has a higher affinity for 9 carbon aldehydes than for 6 carbon lipids and 
has a much greater catalytic efficacy than does GSTA3, making it the primary 
glutathione S-transferase involved in 4-HNE or 4-ONE dependent protein 
carbonylation31.  Glutathionylated lipid metabolites can be further metabolized by 
phase I enzymes ALDHs and AKRs and are eventually exported from the cell by 
the Ral-binding GTPase activating protein RLIP76 or multidrug resistance protein 
132-34.  
 
 
Oxidative Stress in Obese Adipose Tissue 
Research over the last decade has demonstrated that a defining feature in the 
development of metabolic disease in the obese state is elevated oxidative stress 
in the adipose tissue. This observation has generated great interest in three 
central themes: identification of the site/source of ROS production in obese 
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adipose tissue, uncovering the causes of increased oxidative stress in the 
disease state, and elucidation of the pathways/mechanisms that connect 
oxidative stress to metabolic dysfunction and insulin resistance.  
At the cellular level there are several sites within the adipocyte that produce high 
levels of ROS under both physiological and pathological conditions.  For 
example, studies in KKAy mice, a genetic model of hyperphagy, revealed that 
elevated levels of hydrogen peroxide within adipose tissue is associated with 
obesity.35 White adipose tissue from KKAy mice exhibits increased transcript 
levels of multiple NADPH oxidase subunits including gp91phox, the cytosolic 
component p47phox, and p67phox, with no change in transcript levels in liver or 
skeletal muscle35. Consistent with this observation, Pu.1, a transcription factor 
that has been shown to be responsible for increasing transcription of NADPH 
oxidase subunits is up-regulated35.  
 
An additional source of ROS in adipose tissue is xanthine oxidoreductase (XOR), 
which catalyzes oxidation of xanthine/hypoxanthine to produce uric acid and 
forms superoxide anion as a byproduct36.  XOR mRNA expression and 
enzymatic activity are increased in adipose depots from ob/ob mice compared to 
lean controls, indicating that XOR may be a major cytoplasmic source of ROS in 
obese adipose tissue37,38. Interestingly, targeted deletion of XOR or silencing of 
its mRNA reduce ROS synthesis, but also attenuate adipogenesis, suggesting a 
mechanistic link between oxidative stress and preadipocyte differentiation37. 
Indeed, XOR mRNA is upregulated early in the differentiation program of 3T3-L1 
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cells, concomitant with that of peroxisome proliferator activator γ (PPARγ) and 
prior to the classical marker of fat cells, fatty acid binding protein 4 (FABP4).  
These data suggest that XOR-derived ROS may function to activate signaling 
pathways required for adipogenesis.  
 
Mitochondrial respiration is another a major source of ROS under diseased 
conditions. Importantly, mitochondrial antioxidants Gsta4, Prdx3, Gpx4 and Aldh2 
are all down regulated within visceral adipose tissue of both high fat fed C57Bl/6J 
mice as well as ob/ob mice28. Additionally, expression at the transcript level of 
Sod2 is significantly elevated in visceral adipose tissue of ob/ob mice while its 
cytoplasmic isoform remains unchanged28. The increased expression of Sod2 
coupled to decreased expression of Prdx3, GPx4 and Gsta4 suggests that 
enzymatic production of H2O2 and chemical synthesis of hydroxyl radicals may 
drive the oxidative stress phenotype associated with obesity.   
 
Extending this analysis, Curtis et al. have shown that Gsta4 is also down 
regulated in visceral adipose tissue of obese, insulin resistant humans, but not 
obese insulin sensitive individuals, suggesting that the decreased expression is 
linked to metabolic disease rather than obesity, per se.  The molecular 
mechanisms that lead to the decreased expression of Gsta4, Prdx3, Gpx4 and 
Aldh2 are complex and are likely due to inflammatory cytokines.  Indeed, 
treatment of 3T3-L1 adipocytes with either TNF-α, IL-1β, IL-6 or IFNγ leads to 
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decreased expression of the antioxidant genes, implying that immune cell factors 
drive increased oxidative stress and mitochondrial ROS synthesis in adipocytes.  
 
While there are many sites of ROS production in the adipocyte that are relatively 
well characterized, less is known about the upstream signaling events that initiate 
oxidative stress. Substantial evidence from obesity models in rodents as well as 
human studies support a mechanistic link between inflammation and oxidative 
stress, and much recent work has focused on characterizing the pathways and 
signaling events that support this linkage6,39-43.  
 
Adipose tissue is composed of multiple cellular subtypes including adipocytes, 
macrophages, pre-adipocytes and endothelial cells. It has long been appreciated 
that adipose tissue under obese conditions is characterized by a state of chronic, 
low grade inflammation, and during the transition from lean to obese the 
population of pro-inflammatory immune cells increases, occupying up to 40% of 
the adipose tissue itself44. Additionally, pro-inflammatory cells communicate in a 
paracrine fashion with the adipocyte through secretion of cytokines like TNF-α, 
IFNγ, IL 1β and IL-644. Increased concentrations of these markers in adipose 
tissue positively correlates with insulin resistance in humans and rodents45.  
 
Interestingly, although obesity and metabolic syndrome are tightly linked, there 
remains a subset of obese individuals who maintain insulin sensitivity46,47. These 
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metabolically healthy, but obese individuals confirm that obesity and metabolic 
disease can be uncoupled48. Indeed, there are many mouse models that de-
couple obesity from insulin resistance49-51. These models have been crucial tools 
for understanding metabolic disease.  Importantly, evidence from these models 
has indicated that, in general, insulin sensitivity is maintained under obese 
conditions when the adipose tissue does not transition to a proinflammatory 
state.  Conversely, insulin resistance is positively correlated with inflammation, 
particularly within visceral adipose depots52,53. As such, it has been suggested 
that the presence or absence of pro-inflammatory cells within specific adipose 
tissue beds is a good indicator of whole body insulin sensitivity and metabolic 
health.  
 
Anatomically, adipose tissue is typically deposited either intra-abdominally or 
peripherally.  Intra-abdominal, or visceral adipose tissue is composed of adipose 
depots that surround organs within the abdominal cavity. Conversely, 
subcutaneous adipose tissue is categorized as adipose tissue accumulating 
directly beneath the skin. Previously, increases specifically in intra-abdominal 
obesity have been correlated with decreased insulin sensitivity, increased 
circulating triglycerides and concomitant decreases in high-density lipoprotein 
levels54,55. Consistent with this observation, in humans after adjusting for body 
mass index, individuals with increased visceral adipose tissue mass also had a 
greater level of insulin resistance, whereas individuals with an increase only in 
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subcutaneous adipose tissue mass showed a decreased risk for insulin 
resistance54. Generally, it is the pro-inflammatory phenotype is specific to the 
visceral depots under obese conditions. 
 
In order to evaluate molecular mechanisms that may contribute to the differences 
observed in visceral and subcutaneous adipose depots, Long et al analyzed 
transcriptional antioxidant expression within each depot from both ob/ob mice as 
well as high-fat fed mice. Overall Prdx3, Gpx4 and Gpx3 expression did not 
change significantly in subcutaneous tissue in either high fat fed mice or ob/ob 
mice, whereas the same antioxidant profile was decreased in the visceral 
adipose tissue depot28. Additionally, unlike the visceral adipose tissue from high 
fat fed C57Bl/6J mice, the subcutaneous adipose tissue showed a significant 
decrease in free aldehyde levels28.   Analysis of protein adducts modified by 4-
HNE and 4-ONE revealed a significant decrease in protein carbonylation in the 
subcutaneous and a significant increase in the visceral depots of high-fat fed 
mice compared to lean controls28. In the KKay mouse model, hydrogen peroxide 
is elevated selectively in the visceral adipose tissue with no change in oxidative 
stress in liver, skeletal muscle or aorta at seven weeks of age35. These data 
indicate that it is primarily the inflamed adipose depots (visceral) that exhibit 
oxidative stress and protein carbonylation.  This is consistent with a model in 
which adipose inflammation, oxidative stress, and protein carbonylation are 
tightly linked in the obese state.  
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Protein carbonylation in the adipocyte 
The generation of reactive lipid aldehydes in adipose tissue is intimately linked to 
oxidative stress due to the carbonylation of lysine, cysteine, and histidine 
residues.  Carbonylation is the chemical, non-enzymatic nucleophilic addition of 
the aldehyde to the side chain of lysine, histidine, or cysteine residues at the lipid 
C3 carbon, producing a covalent lipid adduct on proteins.  Following Michael 
addition, intramolecular rearrangement can occur to generate the more stable 
hemi-acetal56-58. Schiff base formation via the primary amine of lysine residues 
can also occur, resulting in dehydration of the aldehyde and loss of the free 
carbonyl.  These events are technically not protein carbonylation since the 
definition has historically been operational through carbonyl-reactive probes, but 
is often considered in the same class of modifications due to the addition of the 
lipid aldehyde to lysine residues.  Michael adducts are generally more stable and 
believed to account for the majority of protein-lipid adduction events59,60.  
  
There are several properties of carbonylation that distinguish it from other well-
known types of protein modifications.  Most importantly, carbonylation occurs via 
a non-enzymatic mechanism.  Furthermore, there are currently no known 
enzymes that can remove the modification.  Thus, unlike phosphorylation, which 
is regulated by kinases and phosphatases, or acetylation that is controlled by 
acetyl transferases and deacetylases, carbonylation is subject to a much less 
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stringent regulatory cascade.  Despite this quality, it is clear that specific proteins 
are highly susceptible to modification, though the regulatory mechanisms that 
contribute to the specificity of these events are not well understood.   
 
Although increases in ROS can initiate a wide variety of effects throughout the 
cell, protein carbonylation has garnered much attention as a primary outcome of 
oxidative stress in obese adipose tissue.  Two key points illustrate this logical 
framework: first, the adipocyte contains a large lipid droplet, which is believed to 
be a rich potential source for aldehyde synthesis.  Second, as mentioned 
previously, many of the mitochondrial antioxidants involved in reducing lipid 
peroxides (Gpx4) and detoxifying lipid peroxidation products (Aldh2 and Gsta4) 
are transcriptionally down regulated in obese, visceral adipose tissue.  This 
expression pattern of antioxidants effectively channels ROS towards lipid 
peroxidation, resulting in elevated reactive lipid aldehyde pools (4-HNE, 4-ONE, 
and 4-HHE) within the adipocyte (Figure 3). Consistent with this, Long et al. 
measured significantly increased free levels of 4-HNE and 4-ONE in visceral 
adipose depots of high fat fed and ob/ob mice compared to lean controls61.   
 
Importantly, multiple studies have reported increased protein carbonylation by 
reactive lipid aldehydes in adipose tissue. In wild-type mice fed a high fat diet 
protein carbonylation is significantly increased compared to lean controls in 
visceral adipose depots6,61. In humans, adipose tissue protein carbonylation is 
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positively correlated to body mass index and obese humans exhibit a significant 
increase in protein carbonylation in whole cell extract from subcutaneous fat 
depots compared to lean controls54. In cultured adipocytes, treatment with the 
inflammatory cytokine TNF-α or knockdown of antioxidant GSTA4 results in 
elevated protein carbonylation11,62.    
 
Together, the combined observations of decreased antioxidant capacity, 
specifically those that detoxify lipid peroxides and elevate hydrogen peroxide 
support a model in which the ROS produced in obese adipose tissue is 
channeled towards the production of reactive lipid aldehydes such as 4-HNE, 4-
ONE, and 4-HHE (Figure 3). The observed increases in protein carbonylation in 
adipose cell lysates support the hypothesis that protein carbonylation is a 
mechanism by which elevated oxidative stress initiates metabolic dysfunction, 
particularly in the mitochondrion.        
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Figure 3. Oxidative stress and antioxidant expression in obese adipose 
tissue. 
Expression of major antioxidant enzymes is downregulated in the transition from 
the lean to obese state.  As a result, ROS is channeled towards the formation of 
reactive lipid aldehydes and protein carbonylation.   
 
 
Additional outcomes of oxidative stress 
While protein carbonylation is the focus of this chapter, it is important to 
acknowledge other types of protein modifications that can occur in response to 
increased oxidative stress.  Primarily, alterations in the redox status of proteins 
by ROS plays an important role both physiologically as well as under diseased 
states41,63-65. Specifically, hydrogen peroxide is thought to play a large role in 
altering the redox state of proteins.  Even at low levels, H2O2 can oxidize a 
variety of targets within the cell, resulting in altered protein function and signaling 
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pathways.  Hydrogen peroxide is capable of oxidizing sulfur atoms of either 
cysteine or methionine containing proteins (Figure 1).  Although methionine 
oxidation is known to occur, its physiological effects on protein function has been 
limited to only a few well-characterized systems.  
 
It is estimated that approximately 10% of all cysteine residues within the 
proteome are redox sensitive.41 Additionally, the sulfur atom, found on cysteine 
residues, can exist as a thiolate anion (-S-), a free sulfhydryl (-SH), sulfenic acid 
(-SOH), sufinic acid (-SO2H), sulfonic acid (SO3H) and as a disulfide (-S-S)41. For 
a given cysteine residue, each oxidation state can have a profound effect on 
protein conformation, intermolecular interactions, intrinsic activity and 
degradation66.  Although hydrogen peroxide is capable of oxidizing free 
sulfhydryls of cysteine residues, this reaction is unfavorable under physiological 
conditions.  Conversely, hydrogen peroxide is much more reactive with the 
thiolate anion.  Under physiological conditions the pKa of solvent exposed 
cysteine residues is about 8.3 and therefore, most cysteine residues exist in the 
protonated form65,66. Interestingly, because not all proteins contain cysteine 
residues in the thiolate form, this offers a level of targeted specificity for oxidation 
by hydrogen peroxide41,66.  Unlike other oxidation states, sulfenic acid can be 
reduced by the enzyme thioredoxin consuming reduced glutathione65,67. Although 
the effects of ROS are primarily discussed under diseased states, it is important 
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to note that redox state switching is a process that occurs both physiologically 
and pathologically.   
 
Detection of Protein Carbonylation 
Protein carbonylation has taken the spotlight in the field of oxidative stress as a 
likely mechanism by which oxidative stress initiates metabolic dysfunction and 
disease.  As such, there is an enthusiasm in the field to I) identify proteins that 
are targets of carbonylation and II) characterize how carbonylation of target 
proteins changes in response to oxidative stress.  Here, we will briefly discuss 
techniques that have been used successfully to assess carbonylation in adipose 
tissue or cultured adipocytes.  The reader is referred to excellent chapters in this 
volume that focus exclusively on carbonylation detection methodologies.  
 
 
Due to the lack of quantifiable properties (UV, spectrophotometric fluorescence 
or absorbance) of peptides with free carbonyl groups, the detection of 
carbonylated proteins has largely relied on the use of chemical probes that react 
with free carbonyls68,69. Carbonyl reactive probes have been successfully used 
for profiling carbonylation patterns and identification of proteins that are 
susceptible to carbonylation in adipose tissue.  Due to the high content of lipid in 
fat tissue, adipocytes pose a unique challenge to carbonylation research.  
However, several systems have been successfully employed to assess 
carbonylated proteins.  
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2,4-Dinitrophenylhydrazine (DNPH) and biotin-hydrazide (BH), as used by 
Regnier and colleagues, are the two most widely used carbonyl-reactive probes. 
These two reagents share in common a hydrazine-like group that undergoes a 
condensation reaction with free carbonyls.  This effectively labels carbonylated 
proteins and allows for relatively straightforward detection and analysis of labeled 
proteins using biochemical methods specific for the probe (Figure 4). It was 
DNPH-derivitization of carbonyls that was first used to show that protein 
carbonylation does not occur equally across the proteome, but rather that 
specific proteins are subject to oxidative damage by carbonylation under 
conditions of oxidative stress, an observation that was fundamental for our 
understanding of the oxidative stress response70.  In addition, anti-DNPH 
antibodies used in concert with fluorescent secondary antibodies can be used to 
assess protein carbonylation by western blot, a method that has been widely 
employed to study protein carbonylation profiles in response to oxidative stress71.  
 
The biotin hydrazide probe, like DNPH, forms a hydrazone bond with 
carbonylated substrates.  This method capitalizes on the strong affinity between 
biotin and avidin (or streptavidin) as it enables detection, capture, and analysis of 
biotinylated proteins using well-established avidin-based reagents.  Beyond 1D 
western blotting, biotin hydrazide has been used successfully in 2D profiling of 
carbonylated proteins, quantitative assessment of protein carbonyl content, and 
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importantly, affinity capture of carbonylated proteins6,11,62,72. This method has 
also been modified to be compatible with mass spectrometry based analysis 
techniques and has been widely utilized in adipose biology. 
 
Though hydrazine-based probes are by far the most popular reagents used to 
derivatize protein carbonyls, it worth noting that the excitement in the field for 
identifying proteins affected by carbonylation has led to the development of new 
probes designed specifically for mass spectrometry-based approaches.  One 
such probe, AminoxyTMT, contains a carbonyl reactive amine-oxy moiety that 
reacts specifically with free carbonyls to form an oxime bond and has been used 
by Griffin and colleagues to detect and analyze sites of protein carbonylation.  
The conjugation product is slightly more stable and exhibits increased specificity 
for carbonyls compared to the hydrazine-containing methods.  Furthermore, its 
compatibility with mass spectrometry techniques renders it an attractive 
alternative to DNPH and BH. 
 
In adipose tissue, many groups have shown that lipid peroxidation products are 
produced at high levels under conditions of oxidative stress61,73.  It has been 
hypothesized that these products constitute the majority of carbonylation events 
that occur in adipose in response to oxidative challenge.  To this end, there are 
commercially available antibodies directed against common reactive lipid 
aldehyde adducts including 4-ONE, 4-HNE, MDA, and acrolein.  These 
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antibodies are now widely used to perform gel-based analyses of modified 
proteins.  
 
Figure 4. Methods for detection of carbonylated proteins 
 
While the number of carbonylation studies is steadily growing, there have been 
only five studies specifically aimed at identifying targets in adipose tissue or 
adipocytes. Overall, the number of proteins identified as carbonylated in models 
of obesity or obese patients is over 400.  There are, however, many other 
proteins have been identified as carbonylated in adipose, but not in the context of 
a proteomic study.  Figure 5 summarizes five proteomic studies. 
  
 Despite the large number of known protein targets, few direct sites of 
modification have been identified, as BH has been the most commonly used 
reagent for untargeted approaches to carbonylation proteomics. Newer reagents, 
such as AminoxyTMT, may increase the ability to identify the specific sites of 
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modification within adipose tissue. The site-specificity may allow for more 
mechanistic studies to be done, thus providing direct evidence of how 
carbonylation effects metabolism and help explain the correlations observed with 
insulin resistance and oxidative stress. 
 
 
Table 1. Proteomic studies of carbonylated targets in adipose tissue 
 
 
Outcomes of Protein Carbonylation 
Since its first report extensive studies have been carried out to identify the 
mechanisms that generate protein carbonyls and develop methods to measure 
global carbonylation levels in biological systems. This work set the foundation for 
second-generation studies focused on using proteomic tools to identify specific 
carbonylated proteins and understanding how these events affect cellular 
metabolism.  Taken together, these studies have yielded three central points: 
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• Hundreds of proteins are modified by reactive lipid aldehydes in 
metabolically active cells such as adipocytes, neurons, and muscle 
cells.  Carbonylation targets include proteins from many distinct locations 
including the mitochondria, nucleus, ER, and cytoplasm. 
• Protein carbonylation is a regulatory mechanism.  It is clear that 
specific proteins become carbonylated, especially under conditions of high 
oxidative stress.  This is an important point for it supports a role for 
carbonylation as a redox-regulated signaling mechanism rather than 
simply an endpoint of oxidative damage.  
• Protein carbonylation is dynamic. Increased oxidative stress results in 
the transition from physiological levels of protein carbonylation to 
pathological levels.  This switch is intimately tied to metabolic dysfunction 
and disease. 
 
Most critically, the emphasis is now aimed at determining how carbonylation 
affects individual protein function and, more broadly, how carbonylation shapes 
cellular processes on a systems level.  Here, we will focus on the major findings 
in adipose tissue, though it is prudent to note that many of these findings are 
relevant to other cell types and disease states as well.   
 
Modification of proteins by 4-HNE and altered function 
Protein carbonylation is often described as oxidative damage with concomitant 
loss of function. Since modification by 4-HNE is believed to be irreversible, a 
leading hypothesis is that carbonylation generally results in permanent disruption 
of proper protein function, targeting it for degradation.  For example, Uchida et al. 
demonstrated that in vitro modification of glyceraldehyde-3-phosphate 
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dehydrogenase (GAPDH) by 4-HNE resulted in decreased enzymatic activity in a 
concentration-dependent manner74. Subsequently, Grimsrud et al6 reported that 
GAPDH is carbonylated in adipose tissue from high fat fed mice6.  Although it 
had been appreciated for many years that GAPDH activity was inhibited by 
oxidative stress, the mechanism underlying this inhibition was unknown.  As 
such, this was a key study because it not only proposed a mechanism for 
oxidative stress dependent regulation of GAPDH function, but it was one of the 
first studies to directly test the effects of carbonylation on protein function.  What 
is not known within the context of cellular metabolism and obesity is if the fraction 
of GAPDH that is carbonylated is sufficient to restrict carbon flow through 
glycolysis.  If so, then oxidative modification of GAPDH may be a protective 
mechanism to attenuate glycolysis and potentiate the pentose pathway 
producing additional NADPH that could be utilized for enhanced glutathione 
synthesis under conditions of increased oxidative stress.  
 
Following these studies, many other groups have shown that modification of 
proteins with 4- HNE can inactivate enzymatic function.  One of the most well 
studied targets of 4-HNE modifications is ALDH2.  ALDH2 is a mitochondrial 
enzyme that catalyzes the oxidation of aldehydes to carboxylic acids, and is most 
well known for its role in alcohol metabolism75.  ALDH2 is also a principal 
antioxidant that detoxifies lipid peroxidation products such as 4-HNE and 4-ONE.  
Notably, decreased ALDH2 activity has been linked to many disease states 
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including certain cancers, neurodegenerative disease, and type II diabetes, a 
topic that was recently reviewed by Chen et al. (2014)75.  In 1991, Mitchel et al. 
showed that 4-HNE can be both a substrate and inactivate ALDH276.  This result 
has since been observed in several different cell types and tissues77-79.  These 
data are consistent with a feed-forward mechanism in which loss of ALDH2 
activity by 4-HNE and/or 4-ONE exacerbates the oxidative environment by 
decreasing the ability of the cell to detoxify the lipids.   
 
Interestingly, during the first mass-spectrometry based proteomic analysis of 
carbonylated proteins in adipose tissue, many antioxidant enzymes were 
identified as carbonylation targets.  In this study, soluble proteins from epididymal 
adipose tissue from mice fed a high fat diet were analyzed using BH derivitization 
followed by LC/MS/MS6.  Using this approach, Grimsrud et al. identified over 35 
proteins that are carbonylated in obese adipose tissue.  Notably, this list included 
not only several members of the aldehyde dehydrogenase family, but also 
peroxiredoxin 1 (Prdx1), glutathione peroxidase 1 (Gpx1), and glutathione S-
transferase M1 (Gstm1)6.  Although it remains unclear how carbonylation may 
specifically impact the function of each of these enzymes, one hypothesis is that 
inhibition of antioxidant function by 4-HNE modification may underlie the 
oxidative stress that is linked to high fat feeding and obesity-linked metabolic 
disease.  
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In addition to the antioxidants identified by Grimsrud and colleagues, KEGG 
pathway analysis of the targets revealed five other pathways enriched for 
carbonylation in obese adipose tissue: carbohydrate/lipid metabolism, signal 
transduction, nucleic acid metabolism, protein synthesis/degradation and 
structural/motor proteins.  One of the most notable proteins in this list is fatty acid 
binding protein 4 (FABP4, aP2).  FABP4 is a cytoplasmic fatty acid binding 
protein and is of particular interest because in contrast to many of the identified 
targets, FABP4 is an adipose-specific protein that facilitates lipolysis and is 
known to play a critical role in obesity induced insulin resistance.  Specifically, 
whole body knockout of Fapb4 results in a general metabolic improvement and 
prevention of metabolic disease80. A caveat of this analysis is that adipose tissue 
contains not only adipocytes, but also immune cells, endothelial cells and pre-
adipocyte stem cells and therefore the cell type in which Fabp4 is carbonylated is 
not known.  Fabp4 is expressed in not only adipocytes, but also macrophages 
and dendritic cells.  Following this initial observation, carbonylation of Fabp4 as 
well as its family member, endothelial fatty acid binding protein (Fabp5), have 
been confirmed in two other studies54,81. While the specific mechanisms that 
connect Fabp4 to the progression of metabolic disease remain complex, it is 
clear that loss of function for this protein has dramatic effects on adipose 
metabolism.  In vitro studies of 4-HNE modified Fabp4 revealed that 
carbonylation at Cys117 attenuated the lipid-binding capacity of the protein, 
consistent with a model in which carbonylation inactivates the protein leading to 
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increased unbound free fatty acids 6. Interestingly, Xu et al. reported that 
increased free unbound fatty acids in macrophages leads to increased 
expression of Ucp2 and attenuation of inflammatory NF-κB signaling 49.  It is not 
known if sufficient molar amounts of Fabp4 is carbonylated in macrophage cells 
to cause an increase Ucp2 expression but it is tempting to speculate that 
oxidative modification of Fabp4 may be a regulatory mechanism to maintain 
metabolic homeostasis.   
 
Another protein of interest in adipose tissue is xanthine oxidoreductase (XOR). 
XOR is translated from a single transcript, but exists as two unique and 
interchangeable forms; xanthine dehydrogenase (XDH) and xanthine oxidase 
(XO).  Although both enzymatic forms convert hypoxanthine to xanthine and 
xanthine to uric acid, XDH reduces NAD+ to NADH while XO reduces molecular 
oxygen, producing superoxide anion 82.  XO is known to be a critical source of 
ROS in many tissues under inflammatory and hypoxic conditions 82,83.  Recently, 
XOR was identified as a target of protein carbonylation in cultured adipocytes 62.  
In this study, protein carbonylation of XOR was significantly increased in Gsta4 
knockdown 3T3-L1 adipocytes compared to control cells, indicating that the 
enzyme is preferentially carbonylated under conditions of oxidative stress in 
adipocytes 62. Interestingly, oxidation of key cysteine residues in XDH is known to 
result in the conversion of the enzyme to XO, the superoxide-producing form 
83,84. As such, although the specific sites of carbonylation have not yet been 
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identified, a reasonable hypothesis is that carbonylation of XDH in obese adipose 
tissue is a mechanism that converts XDH to XO, thereby elevating ROS 
production in a feed-forward loop.  Consistent with this, silencing of XDH/XO in 
3T3-L1 cells results in markedly decreased ROS levels, implying that XO is a 
major source of cytoplasmic oxidative stress. 
 
Carbonylation in cell signaling 
Protein carbonylation is not only known to inactivate the function of individual 
proteins, but is now emerging as a critical regulatory mechanism in cellular 
signaling.  Two examples in the adipocyte include the oxidative stress response 
and programmed cell death/apoptosis.   
 
In the adipocyte, reactive lipid aldehydes are present at low levels under basal 
conditions.  When the cell experiences an oxidative challenge, ROS levels 
increase and 4-HNE levels rise.  One important outcome of this effect is the 
initiation of an oxidative stress response via the nuclear factor (erythroid-derived-
2)-like 2 (NRF2)-Kelch-like ECH-associated protein 1 (KEAP1) pathway.  Under 
normal conditions, KEAP1 binds to NRF2 to sequester it in the cytoplasm 85. 
However, when 4-HNE levels rise in response to oxidative stress, KEAP1 
becomes carbonylated at two key cysteine residues (Cys273 and Cys288), 
leading to the release of NRF2 and proteasomal degradation of KEAP1 86,87.  
NRF2 then translocates to the nucleus where it initiates transcription of many 
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crucial antioxidant genes through the interaction with antioxidant response 
elements (AREs), thereby initiating a transcriptional program that allows for the 
cell to recover from the oxidative challenge. This, in turn, ablates the 
carbonylation of KEAP1, allowing it to once again bind to NRF2, effectively 
turning the pathway off. The elucidation of this pathway was important not only 
for our understanding of the antioxidant response, but also because it is a key 
example of a situation in which physiological levels of protein carbonylation act 
as an activating signal in a highly regulated pathway. 
 
The previous example is known to occur under physiological oxidative challenge 
to the cell.  However, when the oxidative challenge outweighs the antioxidant 
capacity, 4-HNE and other lipid peroxidation products rise to a pathological level, 
and are known to be involved in the initiation of programmed cell death via both 
intrinsic and extrinsic pathways.  Specifically, it has been shown that thioredoxin 
(TRX) contains two cysteine residues (Cys32 and Cys35) that are sensitive to 
carbonylation under conditions of oxidative stress 88.  Modification at these two 
residues leads to the release of TRX binding partner apoptosis signal-regulating 
kinase 1 (ASK1).  ASK1 is subsequently activated by autophosphorylation and 
initiates a pro-apoptotic signaling cascade through the activation of key signaling 
kinase c-Jun N-terminal kinase (JNK) 89. Interestingly, other studies have 
attributed JNK activation to transcriptional increases in p53 expression due to 
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high levels of 4-HNE, though the mechanism by which 4-HNE elevates p53 
expression is unclear 90. 
 
Carbonylation and mitochondrial dysfunction 
Mitochondrial dysfunction has long been appreciated to be a hallmark of 
metabolic disease.  In adipose tissue, transition from the lean to obese state is 
coupled with decreased respiration and impaired glucose and lipid homeostasis 
62. Since the mitochondrion is a major source of ROS in adipocytes, and many 
proteins become carbonylated under conditions of oxidative stress, one 
hypothesis is that carbonylation is a molecular link between oxidative stress and 
mitochondrial dysfunction. To test this hypothesis, Curtis et al. generated Gsta4 
knockdown and Gsta4 overexpressing 3T3-L1 adipocytes 11. Previously, it was 
shown that Gsta4 is selectively down-regulated in adipose tissue of obese mice 
and humans, and knockdown in 3T3-L1 cells leads to increased ROS, elevated 
protein carbonylation, and compromised mitochondrial respiration 62.  Consistent 
with these data, Curtis and colleagues observed decreased Complex I activity, 
impaired mitochondrial respiration, increased levels of superoxide anion, and 
decreased membrane potential in Gsta4 knockdown adipocytes compared to 
controls 62.  
 
To identify specific carbonylation targets that contributed to this phenotype, 
Curtis et al. undertook a large-scale mass-spectrometry based proteomic 
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profiling of mitochondrial extracts from each cell line. In this case, a BH labeling 
scheme was utilized coupled with iTRAQ, an isobaric tagging method for 
multiplexing mass spectrometry studies.  This method allowed for quantitative 
comparison of carbonylation of specific targets between Gsta4 knockdown and 
overexpressing cell lines. Using this methodology, over 370 mitochondrial-
specific carbonylation targets were identified. A KEGG analysis of the identified 
carbonylation targets revealed the TCA cycle, oxidative phosphorylation and 
branched chain amino acid (BCAA) metabolism pathways as the top three 
pathways enriched for carbonylation (Figure 6).   
 
The observation of enriched carbonylation of the BCAA metabolism pathway is 
particularly interesting for this pathway has recently been linked to obesity, type II 
diabetes and mitochondrial dysfunction in white adipose tissue 91-93. Furthermore, 
work by Herman et al have shown that adipocytes play a pivotal role in BCAA 
metabolism and readily metabolize BCAAs to lipogenic precursors acetyl-CoA 
and succinyl-CoA 91,94. Recent work from the Bernlohr and Lynch labs have 
shown that inflammation and obesity affect the ability of visceral white adipose 
tissue to transport and metabolize BCAAs fully 95-97. These findings link 
carbonylation, adipose tissue mitochondrial dysfunction and BCAA metabolism.   
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Figure 5. KEGG analysis of mitochondrial protein carbonylation in 
adipocytes.  Schematic representation of key mitochondrial pathways that 
contain carbonylated proteins. The number represents the fraction of pathway 
proteins, based on KEGG analysis, that are known to be carbonylated.  Data 
from Curtis et al., ref 11.   
 
 
Another key finding in the Curtis study was the identification of many proteins in 
the electron transport chain (ETC) that were enriched for protein carbonylation in 
the Gsta4 knockdown cells.  Two noteworthy targets include NADH 
dehydrogenase (ubiquinone) 1α subunit 2 (Ndufa2) and solute carrier family 25 
member 3 (Slc25a3).  Ndufa2 is a subunit of Complex I of the electron transport 
chain, which catalyzes the transfer of electrons from NADH to ubiquinone. 
Slc25a3, which is more commonly referred to as the mitochondrial phosphate 
carrier (PiC), is a critical part of Complex V of the electron transport chain.  PiC 
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functions to transport inorganic phosphate from the inner mitochondrial space to 
the matrix: a step that is required for ATP production by oxidative 
phosphorylation.  The transport activity of the PiC is known to be sensitive to 
cysteine alkylating reagents suggesting that carbonylation may attenuate 
phosphate influx into the mitochondrion 98. Since carbonylation of proteins often 
disrupts proper function, and electron leak from the ETC is a major source of 
ROS, one hypothesis is that carbonylation of critical proteins involved in oxidative 
phosphorylation plays a causative role in the development of mitochondrial 
dysfunction and impaired respiration in adipocytes.  
 
 
Human studies of adipose carbonylation 
Although the number of carbonylation studies in murine-derived cell lines and 
tissue are by far the most pervasive, there have been several studies aimed at 
profiling carbonylation in human-derived cell lines and primary tissue biopsies.  In 
one such study, Singh et al. investigated carbonylation in the human liposarcoma 
cell line SW872 81.  Previously, the authors had observed that treatment of cells 
with glycated albumin led to the accumulation of oxidatively modified proteins. To 
identify modified proteins, SW872 lysates were harvested after treatment with or 
without glycated bovine serum albumin (BSA) and were subjected to DNPH 
derivitization. These lysates were then separated by 2D gel electrophoresis and 
differentially regulated proteins were recovered and subjected to MS/MS 
identification. The eight proteins identified were Annexin A2, β-actin, FABP4, 
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ATP synthase, Annexin V, Aldehyde dehydrogenase, Mitochondrial aldehyde 
dehydrogenase 2 precursor and Annexin VI isoform 1. Notably, there was a 6-
fold increase in Annexin A2 carbonylation and a 4-fold increase in β-actin 
carbonylation in the glycated-BSA treatment compared to controls.  The authors 
concluded that there is a relationship between advanced glycated end products 
(AGEs) and metabolic syndrome. This relationship may the result of increased 
carbonylation of β-actin and Annexin A2, which can interrupt actin dynamics and 
proper cellular function 81.   
 
In 2011, Frohnert et al. undertook a study to investigate the relationship between 
human obesity and carbonylation levels.  In this study, omental adipose tissue 
was obtained from lean and obese patients, biotin-hydrazide derivitized, and 
proteins were separated by 2D-SDS-PAGE. This was the first study to use 
human samples to examine carbonylation levels within the context of the lean-to-
obese transition.  This study demonstrated a positive correlation between 
carbonylation levels within visceral adipose tissue, serum free fatty acids (FFA), 
and body mass index thereby verifying much of what had previously been 
observed in murine obesity models.  In addition, a negative correlation was 
observed between protein carbonylation and insulin sensitivity 54. Finally, in 
agreement with previous proteomic studies, FABP4 and FABP5 were identified 
as targets of carbonylation in the human omental adipose depots.  Although the 
proteomic methods used to identify carbonylation targets was a limiting factor in 
  41 
this study, these findings were paramount in the context of diabetes as it was the 
first study to directly correlate carbonylation and insulin resistance in a human 
population. 
 
More recently, several human studies have focused on the metabolic effects 
following Roux-en-Y gastric bypass (RYGB) surgery.  RYGB is a widely used 
surgical method for treatment of obesity and associated metabolic disease.  
Shortly after RYGB, patients exhibit drastically improved glycemia and improved 
metabolic phenotype prior to significant weight loss.  In order to assess changes 
that occur in white adipose tissue during this shift, subcutaneous adipose 
biopsies were obtained prior to, and 7-8 days following, gastric bypass surgery.  
Interestingly, there was a significant decrease in protein carbonylation following 
surgery 99. This effect was concomitant with decreased homeostatic model 
assessment of insulin resistance and increased expression of mitochondrial 
biogenesis markers.  While the mechanisms that lead to post-operative metabolic 
improvements remain complex, this study suggests that decreases in 
carbonylation directly following surgery may play an important regulatory role.  
 
Concluding Remarks 
Although the number of carbonylation studies is rapidly growing, there remain 
many open questions in the field. Namely, of the hundreds of proteins that have 
been identified as targets of 4-HNE modification, only a handful have been 
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subject to thorough investigation to elucidate specific sites modified and 
determine how, specifically, carbonylation affects protein function in vivo. As 
such, studies aimed at how carbonylation affects protein structure and function 
will be important in moving forward. In addition, many of the proteomic studies in 
adipose and other tissues have focused on mitochondrial targets of 4-HNE 
modification.  Relatively few have considered the effect of carbonylation on 
proteins in other subcellular localizations and even fewer on the signaling roles of 
other types of lipid adducts, such as 4-HHE.  While the mitochondrion is known 
to be the primary producer of ROS in adipose, and therefore has been the focal 
point of oxidative stress studies, molecules like 4-HNE and 4-HHE are readily 
diffusible and it is clear that many proteins in the cytoplasm, ER, and nucleus are 
modified by lipid peroxidation products.  Moreover, lipid aldehydes can diffuse 
across cellular membranes suggesting that protein carbonylation may link 
activities in adjacent cells.  Finally, it is not well understood what happens to 
proteins once they become carbonylated.  While several studies suggest that 
carbonylated proteins are degraded by the proteasome, the details of such 
mechanisms remain unclear.  Moreover, there are no known enzymes that can 
hydrolyze Michael adducts from proteins.   
 
Despite these many open questions, protein carbonylation has emerged as an 
important effector of oxidative stress and cellular metabolism.  Recent work has 
demonstrated that hundreds of distinct proteins are carbonylated within adipose 
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tissue and that these events initiate a wide variety of signaling cascades across 
the cell.  A better understanding of these processes holds great promise for 
future work aimed at elucidating the role of oxidative stress in the etiology of 
obesity and metabolic disease. 
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Abbreviations 
 
Tumor necrosis factor alpha (TNF-α), Interleukin 1 beta (IL-1β), Interleukin 6 (IL-
6), Interferon gamma (IFNγ), Endoplasmic reticulum (ER), 4-hydroxy trans-2,3-
nonenal (4-HNE), 4-oxo trans-2,3-nonenal (4-ONE), Reactive oxygen species 
(ROS),  Superoxide dismutase (SOD), Malondialdehyde (MDA), 4-hydroxy 2,3-
hexenal (4-HHE), Poly unsaturated fatty acids (PUFAs), Arachadonic acid (AA), 
Docosahexaenoic acid (DHA), Peroxiredoxin (PRDX), Glutathione peroxidase 
(GPX),  Lipid hydroperoxide (LOOH), Aldo-keto reductase (AKR), Aldehyde 
dehydrogenase (ALDH), Aldehyde oxidase (AO), Glutathione-S-transferase 
(GST) and Glutathione (GSH), Xanthine oxidoreductase (XOR), Fatty acid 
binding protein (FABP), Thiobarbituirc acid reactive substance (TBARS), 
Aminooxyacetic acid (AOAA), 2,4-Dinitrophenylhydrazine (DNPH), 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Xanthine 
dehydrogenase (XDH), Xanthine oxidase (XO), Nuclear factor erythroid-derived-
2-like-2 (NRF2), Kelch-like ECH-associated protein 1 (KEAP1), Antioxidant 
response elements (AREs), Thioredoxin (TRX), Apoptosis signal-regulating 
kinase 1 (ASK1), c-Jun N-terminal kinase (JNK), Branched chain amino acid 
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(BCAA), NADH dehydrogenase (ubiquinone) 1α subunit 2 (NDUFA2), solute 
carrier family 25 member 3 (Slc23a3), Advanced glycated end products (AGEs), 
Roux-en-Y gastric bypass (RYGB), Bovine serum albumin (BSA). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  45 
 
 
 
CHAPTER TWO 
 
 
Redox regulation of DNA binding proteins and the role of adipose 
nuclear protein carbonylation  
 
 
Amy K. Hauck, Wendy S. Hahn, Tong Zhou, Yue Chen, and David A. 
Bernlohr1 
 
1Department of Biochemistry, Molecular Biology, and Biophysics, University of 
Minnesota, Minneapolis, MN 55455 
 
 
This chapter contains an original research article in preparation to be published. 
 
Wendy Hahn performed EMSA experiments in Figure 5, Amy Hauck, Tong Zhou 
and Yue Chen performed LC-MS/MS experiments and Amy Hauck performed all 
other experiments, analysis, and preparation of the manuscript 
 
  
  46 
Summary 
Oxidative stress plays a causal role in metabolic dysfunction in adipocytes, but 
the mechanisms that contribute to this process remain controversial. In the obese 
state, oxidative stress enables lipid peroxidation and subsequent protein 
carbonylation by diffusible lipid electrophiles. Here, we show the specific 
accumulation of carbonylated proteins in the nucleus of adipocytes in the obese 
state. We developed a novel methodology in order to perform site-specific 
proteomic analysis of lipid carbonylation targets of 4-hydroxy-nonenal (4-HNE) 
and 4-hydroxy-hexenal (4-HHE). Using this method, we identified over 100 novel 
nuclear carbonylation target proteins. Interestingly, 4-HNE and 4-HHE display 
distinct target patterns despite their chemical similarity. Analysis of primary and 
secondary motifs surrounding the sites of modification revealed that that zinc-
coordinating cysteines within zinc fingers are a hotspot for protein carbonylation. 
Analysis of one such target, the transcriptional regulator Estrogen Related 
Receptor Gamma (ERRγ), indicates that carbonylation of the identified cysteine 
results in a dramatic loss in DNA binding activity. Together these data 
demonstrate a novel pattern for protein carbonylation whereby the modifications 
accumulate in the nucleus, potentially driving redox-regulated transcriptional 
outcomes through altered function of DNA binding proteins. 
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Introduction 
Protein carbonylation refers to the post-translational modification (PTM) of the 
side chains of lysine, cysteine, and histidine residues by reactive lipid aldehydes 
such as 4-hydroxy-trans 2,3 nonenal or 4-hydroxy-trans 2,3 hexenal.  1,100.  Such 
lipids are formed in response to oxidative stress and accumulate when reactive 
oxygen species (ROS) are elevated or the cellular antioxidant capacity is 
depleted 61,101. As such, protein carbonylation is largely recognized as a marker 
of pathological ROS production in a variety of cell types and tissues.  Much work 
has focused on identifying protein targets of carbonylation with the goal of 
making specific mechanistic connections between oxidative stress and the 
subsequent development of metabolic disease.  
 
Previous work from our lab and others has demonstrated a striking decrease in 
the expression of major antioxidants in epididymal adipose depots from murine 
models of obesity as well as in cultured adipocytes in response to inflammatory 
stimuli 61,62,102,103. This decrease in antioxidant capacity is coincident with 
elevated ROS and increased levels of select reactive lipid aldehydes within the 
tissue 61,102. This leads to a significant increase in protein carbonylation of many 
different proteins within the adipocyte 6,11,104. Of the antioxidant enzymes, the 
down regulation of glutathione-S-transferase A4 (Gsta4) in response to tumor 
necrosis factor α is particularly noteworthy.  This enzyme is a major route for 
detoxification of reactive lipid aldehydes and depletion of Gsta4 in vivo leads to 
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elevated protein carbonylation, oxidative stress, mitochondrial dysfunction, and 
impaired insulin signaling 11,62.  Consistent with glutathionylation of reactive 
aldehydes being linked to insulin action but not obesity per se, human GSTA4 is 
down regulated in the obese, insulin resistant but not the obese insulin sensitive 
state 62.  Moreover, in worm models of glutathione S-transferase deficiency 
(C.elegans gst10), lifespan was attenuated and following rescue with murine 
Gsta4, lifespan was potentiated105 suggesting that protein carbonylation plays a 
fundamental role in longevity.  Together these observations strengthen the 
hypothesis that oxidative stress and subsequent protein carbonylation play a 
causal role in metabolic disease. 
 
Several large proteomic studies in a variety of disease models have aimed to 
identify carbonylated proteins and to characterize the effect of protein 
carbonylation on function 11,106,107.  Although these studies were successful in 
that they identified many protein targets, and, in a few cases, demonstrated 
direct impact on protein function, several shortcomings still remain.  Firstly, most 
of the proteomic studies to date lack site-specific information, making functional 
studies challenging and time-consuming.  Secondly, of the proteins identified so 
far, very few have been shown to play a major role in the metabolic deficiencies 
observed in obesity (or other disease) models.  Thirdly, the workflow for several 
proteomic analyses have relied on exogenous addition of reactive aldehydes to 
cells rather than defining endogenously modified proteins.  Finally, much of the 
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previous work for protein carbonylation had been directed at mitochondrial 
targets, as this is a major ROS-producing organelle.  
 
In this study, we present the novel finding that protein carbonylation 
endogenously accumulates in the nucleus of adipose tissue and modifies critical 
metabolic transcriptional regulators in the obese state.  Furthermore, we have 
generated a method by which to identify these proteins and obtain site-specific 
and lipid-specific information.  Importantly, this not only allows for more facile 
study of carbonylated targets but also allows for more broad analysis of 
carbonylation patterns and motifs. 
 
Materials and Methods 
Animal protocol 
Wild-type C57Bl/6J mice were weaned at 3 weeks of age and then fed either a 
high fat diet (20% protein, 35.5% fat, 36.3% carbohydrate; BioServ F3282) or a 
chow diet for 12 weeks. Animals were sacrificed by cervical dislocation and 
epididymal and inguinal white adipose depots were removed for analysis. 
Experiments were carried out were approved by the University of Minnesota 
Institutional Animal Care and Use Committee. 
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Cell Culture 
3T3-L1 fibroblasts were grown to confluence and differentiated as previously 
described108 using the standard differentiation cocktail consisting of 
dexamethasone, methylisobutylxanthine, and insulin. On day 7 of differentiation, 
cells were treated with 10 uM erastin (Cayman Chemical 177754) or vehicle 
(DMSO) in DMEM +5% Fetal Bovien Serum (FBS) for 24 hours before harvesting 
or for use for microscopy experiments. For ERRγ inhibitor experiments, day 8 
cells were treated with 10 uM GSK5182 (Aobios AOB1629) or vehicle (DMSO) 
for 6 or 20 hours. 
 
Nuclear lysate preparation 
Fresh tissue was minced on ice in hypotonic lysis buffer (10 mM Tris-Cl pH 8.0, 1 
mM KCl, 1.5 mM MgCl2, 1mM DTT) with protease and phosphatase inhibitors. 
Tissue was homogenized with a glass-Teflon system using an electric 
homogenizer (8 strokes, 1600 rpm). Samples were spun at 1000 rpm at 4°C for 
10 minutes and the fat cake was discarded. Then, samples were briefly vortexed 
and spun at 3700 rpm at 4°C for 10 minutes to collect nuclei. For several 
experiments, the post nuclear extract was stored for western blotting analysis. 
Nuclei were washed 3X before use in subsequent analysis. Nuclei were 
resuspend in reduction buffer (15mM  NaBH4 in PBS) in incubated for 30 min. 
Samples were dialyzed overnight into PBS, sonicated, and spun (16000 rpm at 
4°C for 10 min) to remove nuclear debris. Samples were quantitated with the 
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bicinchoninic acid protein quantitation assay (Sigma Aldrich) prior to downstream 
applications. For western blotting, samples NP-40 and SDS were added to a final 
concentration of 1% and .1% respectively to samples.  For mass spectrometry 
experiments, histone proteins were separated from other nuclear proteins by acid 
extraction prior to analysis. 
 
Glutathione content assay 
This was performed using the GSH/GSSG Ratio Detection Kit (Abcam 65393) 
according to manufacturer’s instruction.  
 
Western blotting analysis 
Samples were prepared for western blot by mixing normalized samples with 4X 
loading buffer. Samples were resolved by SDS-PAGE, wet transferred to PVDF 
membrane, blocked for 1 hour with blocking buffer (LI-COR 927-4000) and 
incubated with primary antibodies overnight at 1:1000 dilutions in TBS-T + 5% 
BSA. Membranes were then washed 3X in TBS-T and incubated for 1 hour with 
fluorescently labeled secondary antibodies (LI-COR) and imaged using the LI-
COR Odyssey Imager. Antibodies used include 4-HNE (Millipore, 393207), 4-
HHE (non-commercial), β-Actin (Sigma-Aldrich A5441), Histone H3 (abcam 
10799), Histone H4 (Cell Signaling 2935S). ERRγ (abcam ab128930), ERRα 
(Thermo Fisher, H5844). 
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Immunofluorescence and microscopy 
3T3-L1 fibroblasts were grown on coverslips (#1.5 coverslips, EMS72224-01) in 
6-well plates. Cells were differentiated according to normal protocol and treated 
with erastin or DMSO for 24 hours on day 7. On day 8, cells were fixed with 4% 
paraformaldehyde (EMS15714). Cells were blocked and permeabilized with 
blocking buffer (PBS, .1%Triton X-100, .2% gelatin, 1% BSA). Cells were 
incubated with primary antibody (α-4-HNE, abcam 46545) overnight and washed 
with PBS + .1%TX-100. Cells were then incubated with secondary antibody at a 
1:1000 dilution (Donkey anti-rabbit IgG Alexa Fluor 488, abcam 150073) and 500 
nM DAPI for 30 minutes. Following washing, cells were mounted on slides with 
mounting solution (Invitrogen P10144) and stored at 4° until imaging. Slides were 
imaged at the University of Minnesota Imaging Centers using the Olympus 
FV1000 Bx2 upright confocal microscope at 60X with an oil immersion lens. 
 
Immunoprecipitation of carbonylated proteins  
For IP of proteins, 70-100 µg of reduced nuclear extract (in PBS) was diluted to 
500 ul with a PBS+ 1% NP40 and then was pre-cleared with protein A/G agarose 
resin (Sant Cruz sc-2004). 4-HNE primary antibody (Millipore 393207) was cross-
linked to protein A/G agarose resin using DMP imidoester crosslinking reagent 
(Thermo Scientific) according to manufacturer’s instructions. Cross-linked 
antibody/resin was incubated with nuclear lysates overnight. The next day, resin 
was washed 3X with RIPA buffer and proteins were eluted by boiling in 4X DNS. 
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Samples were resolved by SDS-PAGE, stained with Imperial Protein Stain 
(Thermo Scientific) prior to in gel digestion.  
 
In gel digestion 
SDS-PAGE gel bands were first washed by 50% EtOH in water for overnight and 
then washed by water for an hour. Each gel band was cut into small pieces and 
then dehydrated by acetonitrile. Proteins were reduced and alkylated at room 
temperature in dark by TCEP (15 mM) and iodoacetimide (45 mM) in PBS. Then 
the gel pieces were washed sequentially by 50 mM ammonia bicarbonate, 100% 
acetonitrile, and dried completely by SpeedVac (ThermoFisher). Trypsin stock 
solution (Promega) was reconstituted in 50 mM ammonia bicarbonate buffer to 
10 ng/µl and applied to digest proteins in-gel for overnight at 37 °C. Peptides 
were extracted sequentially by Extraction Buffer (5% trifluoroacetic acid and 50% 
acetonitrile in water, v/v) and 100% acetonitrile. The pooled peptide extracts 
were dried in SpeedVac and then desalted by C18 Stagetip as previously 
described.109  
 
In solution protein digestion and immunoprecipitation of peptides 
Proteins were resuspended in the urea lysis buffer (9M urea in PBS [pH 7.2] with 
HALT protease inhibitor cocktail (Thermofisher)). Proteins were subjected to 
reduction and alkylation at room temperature in dark by TCEP (10 mM) and 
iodoacetamide (30 mM) in PBS. Excessive amount of iodoacetamide were 
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quenched by Cys (30 mM). After six fold dilution with PBS, proteins were 
digested by sequencing-grade trypsin (1:50 enzyme to substrate ratio, w/w) 
(Promega) at room temperature for overnight, followed by a second tryptic 
digestion (1:100 enzyme to substrate ratio, w/w) for 3 hours. Peptides were 
desalted with Sep-pack C18 cartridge (Waters) following the manufacturer’s 
instructions. Following digestion, samples were incubated with 4-HNE-agarose 
cross-linked resin overnight and eluted with .1% TFA. 
 
LC-MS/MS 
Peptides were reconstituted in HPLC buffer A (0.1% formic acid in water, v/v) 
and injected into a Proxeon Easy nLC 1000 HPLC system (ThermoFisher) by 
autosampler. Peptides were separated by C18 column packed in-house (15 cm × 
75 µm, ReproSil-Pur Basic C18, 2.5 µm, Dr. Maisch GmbH) with a linear gradient 
of 5%-35% HPLC buffer B (0.1% formic acid in acetonitrile, v/v) at a flow rate of 
200 nl/min. Eluted peptides were directly electrosprayed into the Fusion Orbitrap 
mass spectrometry (ThermoFisher). The instrument was operated in a data-
dependent mode with full mass spectra were acquired with a resolution of 
120,000 FWHM at 200 m/z and MS/MS spectra were acquired using collision-
induced dissociation (CID) with 35% collision energy for detection in the ion trap. 
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MS data processing 
Raw MS data were processed by MaxQuant software (v 1.5.3.12) for protein 
identification.110 Variable modifications include carbamidomethylation on cysteine 
and lysine, methionine oxidation, protein N-terminal acetylation, HNE and 
reduced HNE on cysteine, histidine and lysine, as well as HHE and reduced HHE 
on cysteine, histidine and lysine. Trypsin was selected as the proteolytic enzyme 
and a maximum of two missing cleavages were allowed. The precursor ion mass 
tolerance was set to +/-4.5 ppm and the fragment ion mass tolerance was set to 
+/-0.6 Da. MS data were searched against the Uniprot mouse database 
(released on 2013/09/27 and containing 43310 sequences).  Peptides were 
filtered with a 1% False Discovery Rate (FDR) at the peptide, protein and 
modification site levels.  A minimum Andromeda score of 40 was required for the 
identification of modified peptides. 
 
Bioinformatic Analysis 
Pathway and functional annotation enrichment was performed using DAVID 
bioinformatics resources111,112. All statistics reported are Benjamini-Hochberg 
corrected P-values. Molecular function categorization was performed using 
PANTHER113. Statistical analysis of enriched motifs was performed using motif-x 
114,115. Network analysis was performed using Ingenuity Pathway Analysis 
(https://www.qiagenbioinformatics.com/products/ingenuitypathway-analysis) 
 
  56 
Cloning and expression of GST-ERR2 
We obtained the ERR2-DBD in pET24a vector as a kind gift from Peter Wright. 
We subcloned the original construct into pGEX2T in order to tag with GST using 
the following primers: ERR2 pGEX Fwd ; 
CACCGGATCCGCTATCCCGAAGCGCCTGTG, ERR2 pGEX Rev ; 
CGATGAATTCTTAAGAGTTTTCGC ATCCA. We then expressed in BL21 LysS 
E. Coli. GST-tagged protein was purified using GSH-column chromatography, 
eluted with Elution buffer (50mM Tris, PH 8.0, 100 uM ZnCl2, 10 mM GSH).  
 
In vitro modification with 4-HHE 
Purified protein was dialyzed into Adduction Buffer (100 mM potassium 
phosphate pH 7.4, 150 mM NaCl). Samples were treated for 1-48 hours with .5 
mM 4-HHE (Cayman Chemical 32060). Reaction was quenched with 5 mM DTT. 
Modification was verified by western blotting. 
 
q-RT-PCR 
Cells were washed in PBS and RNA was isolated using TRIzol reagent 
(Invitrogen) according to the manufacturer’s instructions. Real-time amplification 
was performed using a Bio-Rad iCycler thermocycler with iQ SYBR Green 
Supermix. Gene expression assays were performed for Atp2a2, Cpt2, Ndufs2, 
Pdk4, and Txn2. Primer pairs are listed in Table 1. Relative gene expression was 
calculated using transcription factor 2E (TFIIE) as an endogenous control. 
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Electromobility Shift Assay (EMSA) 
10 ul of purified protein was combine with 2 ul 10X binding buffer (100 mM Tris 
pH 7.5, 500 mM KCl, 10mMDTT), 1 ug Poly dI dC, 2 ul 25 mM DTT, 2.5% 
Tween-20, 1 ul DNA probe, and water to final volume of 20 ul. Reactions were 
incubated for 20-30 minutes in the dark. 10 loading dye was added to each 
reaction and Electrophoresis was carried out using 5% TBE Criterion Precast 
Gels (#3450048) in TBE running buffer. Gels were imaged using the LI-COR 
Odyssey Imager. The following IR700 probes were used: forward, 
/5IRD700/TCGAGCATTGATCAAGGTCAGTGATGC. Reverse 
(/5IRD700/TCGAGCATCACTGACCTTGATCAATGC. 
 
Biotin-hydrazide derivitization and immunoprecipitation 
Nuclear extracts (from 1 mg starting tissue) were diluted to 1 mL with biotin 
hydrazide coupling buffer (100 mM sodium acetate, pH 5.5, 20 mM NaCl, 0.1 mM 
EDTA, 2% SDS, protease inhibitors). Biotin hrydrazide (Pierce 21339) was 
added to a final concentration of .5 mM and reactions were incubated for 2 hours. 
Samples were dialyzed into PBS. Samples were incubated overnight with 
streptavidin-conjugated agarose (Thermo Scientific 20357). Samples were spun 
to collect resin. Resin was washed 3X with PBS + .01% SDS, resuspended in 2X 
DNS and boiled to elute proteins. The supernatant was retained and pooled with 
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the washes to assess the non-carbonylated fraction. The entire IP fraction and 
supernatant were loaded into each well to compare ERRγ/α content. 
 
Statistical Analyses.  All statistical analyses were done using unpaired two-tailed 
student’s t-tests with significance level set at p<0.05. 
 
Table 1. q-RT-PCR primer pairs  
 
Results 
Carbonylated proteins accumulate in the adipocyte nucleus 
To assess protein carbonylation in adipose tissue we compared 4-HNE adducts 
formed in epididymal (eWAT) and inguinal (iWAT) depots of C57Bl/6J mice using 
an antibody directed towards 4-HNE Michael adducts.  Michael adducts 
represent >90% of all carbonylation events 59,116,117 and are largely formed via 
alkylation of cysteine, lysine and histidine side chains.  In agreement with 
previous work 61, whole cell extracts of white adipose tissue from both chow-fed 
and high-fat fed mice exhibit extensive 4-HNE modification of proteins (Figure 
1A).  Previous studies have focused on mitochondrial targets of 4-HNE 
modification due to the relatively high local production of reactive oxygen species 
(ROS) 11,62,118.  Interestingly, while previous studies have delimited clear 
differences in ROS accumulation in the mitochondria from lean and obese 
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animals as well as differences in the carbonylation status of individual proteins, 
whole mitochondrial extracts of eWAT from lean and obese animals did not 
exhibit a significant global difference (Figure S1A) and as such, we evaluated 4-
HNE-protein adducts formed in other subcellular localizations.  Unexpectedly, we 
identified a striking accumulation of 4-HNE modified proteins in nuclear extracts 
of HFD-fed mice compared to chow-fed animals (Figure 1B).  Furthermore, 
increased nuclear protein carbonylation was specific to the eWAT depot as levels 
of carbonylated proteins in samples from iWAT between chow and HFD-fed 
animals were largely unchanged (Figure 1B).  
 
To evaluate the biology of nuclearly carbonylated proteins, we utilized the 
cultured 3T3-L1 adipocyte cell system 108.  Differentiated 3T3-L1 cells exhibit 
reduced glutathione levels and robust protein carbonylation under conditions of 
oxidative stress 119,120.   To reduce cellular glutathione levels and achieve a pro-
oxidative environment in 3T3-L1 adipocytes, cells were treated with erastin.  
Erastin is an inhibitor of the cysteine/glutamate antiporter (system Xc-), and 
treatment (10 µM) results in the depletion of glutathione pools (Figure 1C) 121 
without cytotoxicity or altered cell morphology (Figure 1C, Figure S1B). 
Glutathione is critical for maintenance of redox homeostasis and its depletion 
represents a global cellular oxidative stress phenotype.  In particular, the major 
mechanism by which reactive lipid aldehydes such as 4-HNE and 4-HHE are 
detoxified is through glutathionylation by glutathione-S-transferase A4 62,122. 
Previous work from our lab and others has shown that glutathione S-transferase 
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A4 mRNA and protein are down regulated in the eWAT of obese, insulin resistant 
C57Bl/6J mice 61 and in iWAT in obese, insulin resistant humans 54. As such, 
erastin treatment of 3T3-L1 adipocytes phenocopies glutathione depletion in vivo.  
Confocal immunofluorescence microscopy of erastin-treated cells showed a clear 
co-localization of 4-HNE modified proteins with the DAPI-labeled region 
suggesting that carbonylated proteins accumulate in the nucleus of 3T3-L1 
adipocytes (Figure 1D).  Interestingly, the 4-HNE adducts appeared as distinct 
puncta, but did not overlap with the DAPI staining, suggesting there may be 
specific intra-nuclear sites that are preferentially modified. 
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Figure 1. Protein carbonylation accumulates in the nucleus of adipocytes in 
vivo 
(A) Western blot of 4-HNE protein adducts of whole cell lysates from epididymal 
(eWAT) and inguinal (iWAT) adipose depots from 15-week only mice fed a chow 
or high fat diet (HFD) for 12 weeks. 
(B) Western blot of 4-HNE protein adducts from nuclear lysates from chow- (C) 
and high-fat (HFD) fed mice. 
(C) (Left) Glutathione (GSH) levels in day 8 3T3-L1 adipocytes treated for 24 
hour with 10 µM erastin or vehicle (DMSO). (Right) Light microscope image (60X 
magnification) of control and erastin treated cells. 
(D) DAPI and Alexa Fluor 488 fluorescence (60X) in control and erastin-treated 
cells. 2° only was incubated with Alexa Fluor 488 antibody but no primary 
antibody (α-4-HNE). Merge is the DAPI and AF488 combined with the 
transmitted light image. 
 
 
Site-specific proteomic analysis of nuclear carbonylation 
Several published studies of protein carbonylation have utilized mass-
spectrometry based methods and have led to the identification of numerous 
targets of protein carbonylation 11,123-125.   However, the majority of these studies 
lacked the ability to identify the sites of modification in a high throughput manner.  
Furthermore, the hydrazide- or DNPH-based derivitization method most 
commonly utilized is not specific for lipophilic carbonyl adducts and will recognize 
any free carbonyl, thereby making it difficult to verify what type of modification a 
given protein harbors.  Together, these shortcomings have made functional 
studies of protein carbonylation challenging. Therefore we developed a label-free 
method by which to identify site-specific Michael adducts on nuclear proteins 
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(Figure 2A). This method relies on affinity purification with an antibody directed 
against 4-HNE Michael adducts.  Importantly, this antibody is specific for the 9-
carbon 4-HNE adduct and does not bind to the 6-carbon 4-HHE adducts (Figure 
S1C), allowing for enrichment of proteins and peptides carrying specific linkages.  
 
To identify carbonylated proteins that accumulate in the nucleus, we isolated 
nuclei from eWAT depots from obese C57Bl/6J mice.  We analyzed un-enriched 
samples and samples enriched for adducts at both the protein and the peptide 
level before proteomic analysis to identify peptides carrying 4-HNE adducts 
(Figure 2A).  Shown in Figure 2A are the linear structures of the Michael adduct 
formed between 4-HNE and target amino acids.  It should be noted that linear 
lipid aldehydes adducted onto proteins typically cyclize to form the more stable 
hemiacetal (reference here?).  However, in the workflow, we reduced all adducts 
with sodium borohydride to allow for efficient immunoaffinity capture.  Through 
this workflow we identified 65 proteins and 95 sites of 4-HNE modification (Figure 
2B).  4-HHE is reactive lipid that is closely related to 4-HNE and has been 
studied at length for its role in oxidative stress-related outcomes 24,126-128.  As 
such, we also searched for 4-HHE modifications and identified 134 sites on 57 
distinct proteins (Figure 2B).  Since the antibody we used for enrichment is 
specific for the 9-carbon adduct this suggests that nuclearly carbonylated 
proteins may be organized in a complex or physically associate with each other.  
Interestingly, we did not identify any overlapping proteins or sites for both 4-HNE 
and 4-HHE modification, suggesting that despite their chemical similarly, these 
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lipids display distinct molecular protein targets.  Analysis of the sites of 
modifications revealed a roughly equal distribution between lysine, histidine, and 
cysteine modifications, suggesting that neither 4-HNE nor 4-HHE exhibit a side 
chain preference (Figure 2C).  It should be noted that in this workflow analysis, 
histones were excluded.  We have found that histones are a major nuclear 
carbonylation target and specifics as to their sites, specificity and biological 
impact will be reported separately.   
 
Molecular Function Analysis (PANTHER) of all sites identified revealed that 
roughly one-third of proteins identified exhibit enzymatic activity (Figure 2D 
upper).  The remaining proteins cluster into a variety of categories including a 
large number of nucleic acid binding proteins (Figure 2D, lower).  To further 
assess the physiological significance of carbonylation in the nucleus, we 
performed pathway Gene Ontology (GO) analysis of the combined (4-HNE and 
4-HHE) protein dataset.  Interestingly, there was no significant enrichment for 
biological processes or KEGG pathways (Figure 2D, upper panel & 
Supplementary Table 2). In molecular function enrichment analysis, we found 
that carbonylation substrates were highly enriched for metal binding proteins (adj 
P= 1.2x10-7), nucleic acid binding proteins (adj P= 9.7x10-5), and zinc ion binding 
proteins (adj P=0.005). In addition, keyword enrichment analysis and sequence 
feature analysis revealed that zinc finger-containing proteins were the most 
highly enriched class of proteins (adj P=2.6x10-12) (Figure 2D, lower panel & 
Supplementary Table 2).  
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Figure 2: Site-specific proteomic analysis of 4-HNE and 4-HHE Michael 
adducts  
(A) Workflow diagram for proteomic analysis. eWAT depots were collected from 
mice fed a HFD. Following nuclear isolation, 4-HNE modifications were enriched 
by immunoaffinity purification at both the protein and peptide levels prior to LC-
MS/MS analysis. 
(B) Quantitation of the number of 4-HNE and 4-HHE modified sites and proteins 
identified. 
(C) Distribution of 4-HNE and 4-HHE sites on Histidine (H), Lysine (K), and 
Cysteine (C) residues. Represented as percent of total 4-HNE (upper) and total 
4-HHE (lower) hits. 
(D) Number of proteins identified for molecular function categorization from 
PANTHER (upper). Red bars are subcategories of binding and blue bars are 
subcategories of catalytic activity (lower).  
(E) Gene Ontology Analysis of the nuclear carbonylome with statistical 
enrichment for keywords (upper) and molecular function (lower) (BH adjusted 
Pvalue).  
 
Sequence preference analysis for carbonylation sites 
Using our dataset containing over 100 carbonylated proteins we evaluated the 
amino acid sequence flanking each carbonylation site in order to determine if 
there are sequence motifs that are enriched at 4-HNE or 4-HHE sites.  Firstly, we 
calculated the occurrence of each amino acid surrounding the modification from 
the -7 to +7 positions (Figures 3A, 3B and 3C). This analysis revealed a strong 
preference for cysteine at the +3 position and a cysteine or proline at the -3 
position for both 4-HNE and 4-HHE cysteine modifications (Figure 3A).  
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While the 4-HNE and 4-HHE cysteine modifications displayed clear similarities in 
their flaking sequences, the lysine and histidine modifications did not.  4-HNE 
lysine modifications showed a strong preference for polar charged residues in the 
-2,-1,+1, and +2 positions (Figure 3B).  In contrast, the 4-HHE lysine adduct was 
more commonly surrounded by hydrophobic residues on both sides (Figure 3B).  
4-HNE histidine adducts were flanked by polar uncharged residues on the N-
terminus while the 4-HHE modification was surrounded primarily by hydrophobic 
residues on both sides (Figure 3C).  Overall, lysine enrichment in the flanking 
sequences for all modifications was particularly notable. Analysis of combined 
lysine content for all modifications (Figure 3D), all 4-HNE modifications (Figure 
3E), and all 4-HHE modifications (Figure 3F) shows high lysine content for all 
substrates.  
 
Motif analysis using Motif-X revealed three highly enriched motifs for cysteine 
carbonylation and 1 for lysine modification, with no enriched motifs for histidine 
modification (Figure 3G). The identified motifs are all based upon the location of 
neighboring cysteine residues; for cysteine modification, there was a statistically 
significant enrichment for sites with a cysteine in the +5 position (Figure S2A), 
the +3 position (Figure S2B), or the -3 position (Figure S2C) and for lysine 
modification at the +1 position (Figure S2D). Interestingly, ontology analysis of 
the aligned peptides for each motif indicates that both C-x2-C motifs (Figure S2B, 
S2C) and motif -KC- (Figure S2D) are driven by zinc finger substrates (Figure 
S2F-H) while the motif C-x5-C is not (Figure S2E).  
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Modified AA Motif Score Matched Peptides
Fold 
Enrichment Pvalue
Cys xxxxxxxCxxxxCxx 6.55 17 4.39 <.0006
Cys xxxxxxxCxxCxxxx 6.47 24 3.21 <.0006
Cys xxxxCxxCxxxxxxx 6.49 19 3.81 <.0006
Lys xxxxxxxKCxxxxxx 7.28 16 5.43 <.0009
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Figure 3: 4-HNE and 4-HHE modifications exhibit distinct molecular  
signatures 
(A-C) Analysis of the flanking sequences for cysteine (A), lysine (B), and histidine 
(C) modifications. Site of modification is denoted as position 0 on the x-axis. Bars 
represent the amino acid frequency at each of position from -7 to +7 among all 
peptides for each type of modification. 
(D-F) Frequency of lysine, cysteine, and alanine across the entire nuclear 
carbonylome (D), all 4-HNE modified residues (E) and all 4-HHE modified 
residues (F). Solid line is the frequency of K, C, and A residues in the flanking 
sequences of carbonylated sites. Dotted lines denote the global frequency of K, 
C, and A residues across the murine proteome. 
(G) Motifs identified using Motif-x. Modifications for Cys, Lys, and His were 
analyzed separately. No motifs were enriched in the histidine carbonylation 
dataset.  
 
Zinc-coordinating residues are hotspots for protein carbonylation 
Due to the strong enrichment of zinc-coordinating proteins in our proteomic and 
motif analysis, we explored these proteins further in detail.  93% of 4-HNE- and 
87% of 4-HHE-modified zinc-coordinating proteins were zinc-finger containing 
proteins (Figure 4A). Importantly, 70% of the zinc-binding proteins with 4-HNE 
adducts were modified within the zinc-binding domain, suggesting that zinc 
coordination makes residues particularly susceptible to modification (Figure 4B).  
Roughly a third of 4-HHE adducts on zinc binding proteins were within zinc 
binding domains (Figure 4B). 
 
Of the zinc fingers identified, 50% (19 proteins) were C2H2 zinc fingers (Figure 
4C). The C2H2 zinc finger is a common DNA binding domain that mostly exhibits 
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the motif C-x3-C-x12-H-x3-H 129, where the 2 cysteines and two histidines 
coordinate a single zinc ion (Figure 4D). 11 C2H2 zinc fingers had carbonylation 
sites within the zinc-binding domain.  Alignment of these domains showed that 
the two cysteine residues involved in zinc coordination are common sites for 
modification (Figure 4E). Interestingly, 7 of these C2H2 zinc fingers were found in 
proteins that also contain an amino-terminal Krüppel-associated box (KRAB 
domain)(Figure 4E).  An additional three KRAB-containing proteins were also 
identified (2810021J22RIK, ZFP68, and 2610021A01RIK) with modifications 
outside of the zinc-coordinating sites.  The KRAB domain is generally associated 
with transcriptional repression through the binding of KAP1 (KRAB-associated 
protein 1) and subsequent recruitment of chromatin modifying enzymes 130,131.  
The enrichment of KRAB containing-proteins is intriguing and suggests a 
potential role for protein carbonylation in mediating the effects of these 
transcriptional regulators in adipose tissue.   
 
In addition to the C2H2 zinc fingers, several other types of zinc fingers were 
identified with modifications including (among others) MATRIN, RING, C3H1, and 
N4-type domains.  Analysis of the sites of modification within the non-C2H2 zinc 
fingers revealed an additional 12 carbonylated zinc-coordinating sites (Figure 4F-
I, Supplementary Table 3).  
 
  74 
 
 
 
 
Figure 4: Zinc-coordinating residues hotspots for protein carbonylation 
 
(A) Quantitation of the number of zinc finger-containing proteins among total zinc 
binding proteins in the nuclear carbonylome. 
(B) Quantitation of the number of sites identified that participate directly in zinc-
coordination. Percentage of total sites identified in all zinc-binding proteins. 
(C) Distribution of zinc finger domains amongst all zinc finger-containing proteins 
that were identified. 
(D) Model of a typical C2H2 finger. Blue residues coordinate the zinc ion. 
(E) Alignment of all C2H2 zinc fingers that with modifications identified within the 
zinc-binding domain. Blue highlight are zinc-coordinating residues, red letters are 
sites of modification. 
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(F-G) Examples of other classes of zinc fingers identified in this study; SFA2 
contains a MATRIN TYPE ZF (F), MSL2 contains a RING ZF, NUP2L contains a 
C3H1 ZF, and ERRβ/γ is a NR-C4-type ZF. Blue residues coordinate zinc, red 
denotes modified sites.   
 
 
Functional analysis of estrogen related receptors beta and gamma 
carbonylation 
Due to the central role that zinc-coordination has in stabilizing the DNA-binding 
capacity of proteins 132,133, we hypothesized that carbonylation of zinc-
coordinating residues would disrupt DNA binding.  To directly test this 
hypothesis, we selected estrogen related receptor beta/gamma (ERR-β, ERR-γ) 
to investigate the functional consequences of the identified modification.  The 
estrogen related receptors are a family of three orphan nuclear receptors that 
orchestrate transcriptional responses by binding to estrogen-related response 
elements (ERRE) to activate transcription134.  Expressed in a variety of tissues, 
these receptors are critical for maintaining metabolic homeostasis through the 
regulation of diverse processes including browning, thermogenesis, 
adipogenesis, oxidative metabolism, and lipid metabolism 135-139. Importantly, the 
ERR family of receptors are critical for transcriptional activation of nuclear-
encoded mitochondrial genes 134. 
 
Two 4-HHE modifications were identified in the proteomic screen that were 
located in the DNA binding domain (DBD) of ERR-γ/ERR-β (Figure 5A). Cys155 
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is the third zinc-coordinating cysteine of the second finger within the DBD while 
Lys162 is located immediately adjacent to the carboxyl-terminus of the second 
finger (Figure 5A, 5B). Since the DNA binding domains of ERR-γ and ERR-β are 
identical, it was not possible to distinguish which of these two proteins resulted in 
the tryptic peptide carrying the two modifications (Figure 5C). However, since 
ERR-γ is expressed ubiquitously while ERR-β is expressed primarily in 
embryonic tissues 134, it is likely that the parent protein is ERR-γ (Figure 5C). 
Western blots of nuclear lysates from eWAT showed robust protein expression of 
ERR-γ that is significantly decreased in HFD-fed mice (Figure 5D). Furthermore, 
treatment of 3T3-L1 adipocytes with a specific ERR-γ inhibitor GSK5182 resulted 
in decreased expression of known ERR-γ targets Cpt2, Txn2, Atp2a2 and Ndufs2 
(Figure S3A).   
 
To confirm that ERR-γ is carbonylated, we isolated nuclei from eWAT depots and 
used biotin-hydrazide to biotinylate fee protein carbonyls.  Affinity purification of 
the biotinylated substrates followed by western blotting for ERR-γ in both the 
enriched and supernatant fractions revealed that ERR-γ is detectable in the 
biotin-labeled fraction, indicating that approximately 30% of ERR-γ is 
carbonylated in obese eWAT (Figure 5E, left). Since ERR-α is also expressed in 
white adipose tissue and the sites of modification in ERR-γ are conserved 
between all three ERR’s, we used the same strategy to test whether ERR-α is 
carbonylated in obese eWAT.  Interestingly, a significant pool of ERR-α (~ 50%) 
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is detectable in the biotinylated fraction, suggesting robust carbonylation in white 
adipose tissue (Figure 5E, right). 
 
To study the effects of carbonylation on DNA binding, we generated a GST-
tagged DNA binding domain from ERR-β (referred to as ERR2-DBD) expressed 
in E. coli.  This construct is a good model for binding studies of ERR-γ due to the 
near-complete conservation of the domain between family members and 
between mice and humans (Figure S3B).  To determine the importance of 
lysine162 for DNA binding, we mutated K162 to alanine or arginine and 
performed electrophoretic mobility shift assays (EMSA).  Mutation of K162 to 
alanine results in a nearly complete loss of DNA binding capacity (Figure 5F).  
Similarly, a lysine to arginine mutation to control for electrostatic differences also 
led to a significant decrease in DNA-binding, suggesting that K162 not only plays 
a structural role, but also may play a direct role in sequence-specific DNA 
recognition (Figure 5F).  Next, we in vitro-modified ERR2-DBD with 4-HHE 
resulting in a robust time-dependent increase in protein carbonylation (Figure 
5H).  EMSA analysis of the carbonylated and non-carbonylated ERR2-DBD 
showed a decrease in DNA binding capacity that was dependent on the relative 
level of 4-HHE modification (Figure 5G, 5I). Collectively, these data suggest that 
carbonylation of ERRγ functions to inhibit binding to ERRE’s in the genome, 
thereby preventing transcriptional activation of target genes. 
 
 
  78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
Erra 
Errb 
Errg 
Esrra 75 PKRLCLVCGDVASGYHYGVASCEACKAFFKRTIQGSIEYSCPASNECEITKRRRKACQACRFTKCLRVGMLKEGVRLDRVRGGRQKYKRR 164$
Esrrb 99 PKRLCLVCGDIASGYHYGVASCEACKAFFKRTIQGNIEYNCPATNECEITKRRRKSCQACRFMKCLKVGMLKEGVRLDRVRGGRQKYKRR 188$
Esrrg 124 PKRLCLVCGDIASGYHYGVASCEACKAFFKRTIQGNIEYSCPATNECEITKRRRKSCQACRFMKCLKVGMLKEGVRLDRVRGGRQKYKRR 213$
$ $
**********:************************.***.***:***********:****** ***:*********************** 
$!
C 
D 
Chow HFD 
Errγ 
β-Actin 
Ch
ow HF
D
0.0
0.5
1.0
1.5
R
el
at
iv
e 
Ex
pr
es
si
on
/A
ct
in
****
K162 
C155 
C C
C C
Zn 
C C
C CKAFFKRTIQGNIEYS RFMKALKVGM 
P 
A 
T 
N 
E 
Q 
A 
E 
A 
V 
L 
AIPKRL 
Zn 
G 
D 
I 
A 
S G 
Y H Y 
G 
S 
A 
V 
E 
I 
T 
K R R 
R 
K 
S 
pdb1LO1 
E 
α-ERRg 
IR-Streptavidin 
10
% 
Inp
ut 
IP
: B
H 
Su
pe
rna
tan
t 
10
% 
Inp
ut 
IP:
BH
 
up
ern
ata
nt 
-ERRγ  
IR-Sreptavidin 
10
% 
Inp
ut 
IP:
BH
 
Su
pe
rna
tan
t 
α-ERRα  
IR-Sreptavidin 
F. 
K1
62
 w
t
K1
62
R
K1
62
A
0.0
0.5
1.0
1.5
*
**
**
GST- ERR2 DBD
EM
SA
 s
hi
ft/
 C
oo
m
as
si
e
No
 b
ait
 
W
T 
K1
62
 
K1
62
A 
K1
62
R 
G 
48 
+ 
24 
+ 
4 
+ 
1 
+ 
0 
+ 
4-HHE (h) 
GST-ERR2 DBD 
- 
- 
0 1 4 24 48
NP
C
0.0
0.5
1.0
1.5
4-HHE Treatment (hours)
EM
SA
 s
hi
ft/
co
om
as
si
e
*
** **
Coomassie 
4-HHE  
0      1     4      24    48 4-HHE (h) 
H 
I 
  79 
Figure 5: 4-HHE modification of Estrogen-related receptor beta/gamma 
disrupts DNA binding 
 
(A) Ribbon diagram of the DNA binding domain (DBD) of ERR-β/-γ. Blue spheres 
are zinc ions that are each coordinated by 4 cysteine residues in blue. Red are 
carbonylated sites of modification. Amino acid designations represent the 
location in ERR-β. 
(B) Model of the DBD of ERR-β/-γ. 
(C) Alignment of the DBD of the ERR family members. Blue residues coordinate 
zinc, yellow are those amino acids that differ between ERRα and the other family 
members. 
(D) Western blot of whole cell lysates from chow- and HFD-fed mice (left), and 
quantitation (right). 
(E) Western blot of immunoprecipitated biotin-hydrazide labeled proteins from 
eWAT of HFD-fed mice. IP:BH is the total immunoprecipitated fraction, 
supernatant is all protein remaining post-IP. Biotin label is detected with IR 
Streptavidin. ERRγ (left) and ERRα (right) are both detected in the BH IP lanes. 
(F) EMSA of WT ERR2 DBD, K162A, and K162R mutants (left). Probe only 
control contains no ERR2 DBD. Quantitation normalized to coomassie stain of 
protein (right). 
(G) EMSA of WT ERR2 DBD that has been in vitro modified with .5 mM 4-HHE 
for 0,2,4,24, or 48 hours. 
(H) Western blot of in 4-HHE in vitro modified ERR2-DBD. 
(I) Quantitation of (G) normalized to coomassie stain of protein. 
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Figure 6. Summary: Protein carbonylation of zinc fingers in the adipocyte 
nucleus 
Under lean conditions, ROS production is balanced by antioxidant capacity. 
GSTA4 is a major antioxidant responsible for glutathionylation of reactive lipids, 
allowing for their eventual excretion. Depletion of intracellular antioxidants leads 
to elevated levels of reactive lipid aldehydes and accumulation of nuclear protein 
carbonylation in the obese state. ERRγ is a target of this modification, leading to 
decreased binding capacity to target genes. 
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Discussion 
Protein carbonylation by reactive lipid aldehydes has long been appreciated as a 
direct consequence of elevated reactive oxygen species 140,141 and/or depletion 
of glutathione stores.  As such, carbonylation targets have been studied at length 
in tissues and disease models in which oxidative stress is elevated 142.  In 
obesity-linked insulin resistance a variety of studies have shown that oxidative 
stress plays a causal role in metabolic dysfunction but the mechanism(s) remains 
unclear 
7,143.  In the majority of animal models, and in human biology, accumulation of 
adipose tissue in the visceral depot is a positive risk factor for metabolic disease 
while subcutaneous adipose tissue is considered to often be protective in the 
context of obesity 144.  While oxidative stress and glutathione depletion in the 
visceral depot is linked to insulin resistance, the molecular mechanisms 
connecting such changes to metabolic dysfunction remain poorly characterized.  
Herein, we show that protein carbonylation is selectively upregulated in the 
nucleus of obese eWAT but not in the nuclear fraction of inguinal adipose tissue 
(Figure 1).  Moreover, using 3T3-L1 adipocytes, glutathione depletion using 
erastin resulted in increased protein carbonylation that localized to the nucleus 
as well (Figure 1D).  Prior work from the laboratory has shown that the 
expression of key antioxidants such as peroxyredoxin3, glutathione peroxidase4 
and glutathione S-transferase4 are selectively down regulated in the visceral, but 
not subcutaneous, depot of high fat fed mice and that the decreased expression 
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is correlated with increased levels of reactive aldehydes including 4-HNE 61.   
Whereas plasma membrane NADPH oxidase, endoplasmic reticular Ero1, 
xanthine oxidase/dehydrogenase and the mitochondrial electron transport chain 
have been considered the major sites for ROS synthesis in adipose tissue, the 
specific sites for protein carbonylation have been less well characterized.  The 
results of this study are surprising for they point towards the nuclear localization 
of carbonylated proteins and the potential for transcriptional control by oxidative 
stress-dependent mechanisms.   
 
Analysis of the adipose carbonylome resulted in the identification of over 100 
novel, endogenous targets of protein carbonylation as well as the type of 
aldehyde (9-carbon 4-HNE or 6-carbon 4-HHE) carrying out the modification.  
Contrary to previous work on mitochondrial carbonylation that delimited highly 
enriched pathways 11, the nuclear carbonylome did not exhibit any such bias.  
This is not unusual for chemically driven modifications where enzymatic 
regulation is not a driving factor.  Our previous studies defining cytoplasmic or 
mitochondrial protein targets of carbonylation have been limited in depth due to 
the use of non-specific derivitization methods that do not enable one to 
distinguish between sites of modification or the many possible types of 
carbonylation events 8,11.  Our proteomic workflow (Figure 2A) herein differs in 
several important ways from that utilized previously by our group 11 in that we 
used an antibody specific for 4-HNE to enrich for carbonylated proteins.  This 
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allowed for enrichment of 4-HNE modified substrates and specific identification of 
4-HNE adduction sites.  In addition, we enriched at both the protein and the 
peptide levels. This ensures that even low abundance peptides with the 
modification will be detected.  Importantly, we found that reduction of nuclear 
extracts using sodium borohydride dramatically increased the reproducibility of 
analysis and the yield of carbonylated proteins and peptides.   
 
The major protein group we identified as carbonylation targets were zinc-
coordinating proteins and that the site of modification was typically a residue on 
or adjacent to the zinc coordinating amino acids (Figure 2).  From this analysis 
we also defined the protein landscape surrounding carbonylation sites providing 
for the first time insight into the chemical environment that makes modification 
favorable by endogenous lipid aldehydes.  In general, we found that for both 4-
HNE and 4-HHE carbonylation occurred approximately equally on cysteine, 
histidine and lysine side chains.  For cysteine carbonylation, the most striking 
motif defined by the proteomic analysis was the CX2CX2C motif in which for both 
4-HNE and 4-HHE modification the central modified cysteine residue was flanked 
at the +3 or the -3 position by another cysteine residue.  While there was no 
general motif evident from the modification of histidine or lysine side chains, the 
region surrounding the carbonylated amino acid had a relatively high content of 
basic lysine residues.  Interestingly, analysis of each of the 6 modifications 
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(Figure 3) revealed the presence of a proline residue within the +7 to -7 region 
suggesting the potential for a unique structural determinant for carbonylation.   
 
Our results did reveal a strong enrichment of zinc binding proteins with the 
majority of defined carbonylation sites in zinc-coordinating residues (Figure 4).  
Zinc coordination is generally achieved via a tetrahedral geometry of 4 residues 
that typically includes 2-3 cysteine residues 133. Importantly, the ability of a 
cysteine to participate in zinc binding is dependent on a completely reduced, 
unmodified thiol.  Redox metabolism that is coupled to zinc binding is not 
uncommon; indeed there are many proteins that undergo a redox-switch 
whereby oxidation of a zinc-coordinating residue results in the release of zinc 
and a conformational change in the protein 132. For example, heat shock protein 
33 (Hsp33) is activated in response to oxidative stress and acts to prevent 
protein unfolding and aggregatation 145. Structural studies of the Hsp33 
mechanism revealed that under normal conditions, Hsp33 exists in a monomeric 
state with a tight zinc-coordinating domain on the C-terminus. In response to 
oxidative stress, one of the four zinc-coordicating cysteins is oxidized, leading to 
the unfolding of the C-terminal domain and subsequent dimerization of Hsp33 
into its active state 145.   Importantly, this is most often a reversible process, as 
cysteine thiols can readily be re-reduced resulting in restored zinc binding 
capability 132. As such, it is possible that carbonylation of the zinc-coordinating 
residues identified in this study results in the release of zinc and loss of structural 
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integrity of the domain.  However, since there are no known enzymes that can 
remove 4-HNE and 4-HHE Michael adducts from their substrates, these 
modifications result in the permanent disruption of secondary structure in those 
proteins. 
 
Finally, we explored the functional significance of carbonylation of zinc fingers 
and showed that the ERR family of nuclear receptors are carbonylated in vivo 
and this leads to a severe impairment in DNA binding capacity.  Zinc fingers are 
most commonly observed in DNA-binding proteins and are critical for sequence-
specific DNA binding of a wide variety of proteins involved in transcription, 
replication, and repair 146,147.  It is appreciated that these proteins are sensitive to 
oxidative stress though the mechanisms by which this occurs remain elusive 
132,148.  Our data strongly supports a model by which oxidative stress results in 
carbonylation of zinc finger proteins, disrupting their ability to bind DNA resulting 
in a loss of transcriptional regulation.  4-HHE modification of the ERR-γ is an 
example of one such event that is of critical importance for energy metabolism.  
The site of modification of ERR-α/-γ was within or adjacent to the second zinc 
finger that resides on the helix that caps and is perpendicular to the DNA 
contacting helix.  A large fraction of ERR-α (~ 50%) and ERR-γ (~ 30%) were 
found to be carbonylated.  Consistent with this, many transcriptional targets for 
ERRs are down regulated in the obese state relative to lean controls including 
Cpt2, Txn2, Atp2a2, and Ndufs2 149, leading to the consideration that ERR 
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carbonylation may be functional and selectively reduce gene expression.  The 
ERR-α and ERR-γ are broadly expressed in tissues that have high bioenergetics 
demands.  Although their specific effects and gene targets are broad, they are 
most well known for their role in promoting mitochondrial bioenergetics pathways 
including oxidative phosphorylation, fatty acid oxidation, TCA cycle, and electron 
transport chain proteins 134.  Our data is consistent with a model in which 
oxidative stress leads to the carbonylation of ERR-γ/-α leading to impairment in 
the expression of target genes. 
 
A major unknown revealed by this study is the source of ROS and aldehydes that 
lead to nuclear carbonylation.  When considering either high fat feeding in vivo or 
glutathione depletion in 3T3-L1 adipocytes, there are numerous sources of ROS 
that can lead to 4-HNE or 4-HHE production.  While superoxide anion is highly 
labile and has a short half-life, hydrogen peroxide is relatively stable and able to 
diffuse across membranes to various sites within the cell.  Hydroxyl radicals that 
are the critical ROS agent leading to reactive lipid aldehydes are also highly 
labile and as such, defining the site of ROS synthesis is critical.  In parallel, 
medium chain lipid aldehydes are also capable of rapid diffusion across 
biological membranes and therefore, while the nucleus may be the site of protein 
carbonylation, it is not clear what is the origin of the aldehydes.  The results 
presented herein suggest either reactive aldehyde synthesis in the nucleus or 
retrograde movement to the nucleus from their site of origin.  
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  88 
 
Supplementary Figure 1. Protein carbonylation in adipose tissue.  
(A) Western blot of mitochondrial extracts from chow (L) and high-fat (H) fed 
mice (Left). Ponceau stain of membrane (right)   
(B) Western blot of 4-HNE adducts in nuclear lysates and post-nuclear lysates 
from chow- and HFD-fed mice.   
(C) Cytotoxicity assay of erastin-treated 3T3-L1 adipoctyes. Cells were treated 
with erastin or vehicle (DMSO) for 24 hours.   
(D) Western blot of in vitro modified recombinant histone H4 (rH4) with 4-HNE or 
4-HHE. Normalized to histone H4.  
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Supplementary Figure 2: Motif analysis of carbonylation sites.   
(A-D) Flanking sequence distribution for each of the four motifs identified with 
motif-x.   
(E-H) Gene ontology analysis of the proteins matching each motif with statistical 
enrichment of structural motifs. (Benjamini-Hochberg adjusted P value). 
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Supplementary Figure 3: ERR family of nuclear receptors are carbonylated 
in vivo 
(A) q-RT-PCR of ERRγ targets in 3T3-L1 adipocytes treated with vehicle or 
ERRγ inhibitor GSK1582. 
(2) Amino acid alignment of the DBD of mouse ERRγ(NP_036065) and GST-
ERR2 DBD. Grey highlight denotes the DBD. 
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Table 2. Gene ontology analysis of nuclear carbonylation sites. 
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Table 3. Carbonylation of zinc-coordinating residues in non-C2H2 ZF 
motifs. 
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Summary 
Oxidative stress is long-appreciated hallmark of metabolic disease, though the 
mechanisms that connect oxidative stress to altered metabolism, particularly in 
the mitochondrion, remain poorly understood. Through the study of protein 
carbonylation, the modification of proteins by reactive lipids 4-hydroxynonenal (4-
HNE) and 4-hydroxyhexenal (4-HHE), we identified a novel class of histone 
modifications that are dependent upon obesity and aging in white adipose tissue. 
Using label free proteomics we identified 14 sites of histone carbonylation, 
including sites from both the N-terminal tails as well as sites contained within the 
histone fold. These data provide evidence for a new class of epigenomic 
regulators that has major implications for the progression of metabolic disease. 
 
 
 
Introduction 
Obesity is a chronic, low grade inflammatory state in which increased pro-
inflammatory signaling leads to oxidative stress, altered cellular metabolism, and 
the development of insulin resistance150. Dysregulation at the transcriptional level 
of major metabolic pathways in response to oxidative stress is a phenotypic 
hallmark of obesity102,150. In particular we have observed down regulation of the 
mitochondrial antioxidants as well as the enzymes of the branched chain amino 
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acid and tricarbonxylic acid pathways in response to inflammatory signals61,95,103. 
These data suggest that the mitochondrial proteome is broadly reprogrammed as 
a consequence of obesity-linked inflammation. Despite these observations, the 
mechanisms that link inflammation and oxidative stress to an altered 
transcriptional milieu of metabolic genes in adipose tissue remain unclear.    
 
Oxidative protein damage represents an attractive mechanistic target behind this 
process because it is directly correlated with the levels of reactive oxygen 
species (ROS) present 6,28. In the obese state, oxidative stress is the combined 
result of increased production of ROS and decreased expression of the major 
antioxidant enzymes responsible detoxifying these damaging species1. The net 
result is the channeling of ROS towards the formation of the hydroxyl radical151. 
This species cannot be metabolized and is only reduced by the removal of 
hydrogen atoms from neighboring molecules.  Polyunsaturated lipids (either free 
fatty acids or membrane phospholipids) are particularly susceptible to this type of 
oxidation, ultimately leading to the formation of highly reactive, diffusible lipid 
aldehydes. These aldehydes, such as 4-hydroxynonenal (4-HNE), are subject to 
nucleophilic attack by lysine, cysteine, and histidine residues, resulting covalent 
lipid adducts 1. Although the modification is chemical, it is clear that specific 
proteins are modified. In addition, there is recent evidence that suggests that de-
carbonylation is an enzymatically-driven process and that the steady state level 
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of carbonylation is driven by the balance between chemical modification and 
enzymatic de-modification 152.   
 
Notably, in the obese state protein carbonylation in adipose tissue is increased 
up to three-fold, often leading to protein dysfunction and altered mitochondrial 
output 11,54. As such, identifying and characterizing carbonylation events in 
adipose tissue has been the subject of intense study1. Recent work from our 
laboratory has led to the surprising discovery that the major site for differential 
carbonylation of proteins in adipose is not the mitochondrion, as previously 
believed, but the nucleus. This was an unanticipated result that has opened the 
door for a new mechanistic connection between oxidative stress and nuclear 
regulatory events. Indeed, proteomic evaluation of nuclear carbonylation targets 
revealed that many transcriptional and chromatin-associated regulatory proteins 
are modified in the obese state (Bernlohr lab, unpublished).  
 
Here, we expand upon these studies and describe the post-translational 
modification of histones by reactive lipid aldehydes 4-HNE and 4-HHE. We find 
that the core histones are specific targets of carbonylation and that these 
modifications accumulate in adipose tissue as a consequence of high-fat diet 
(HFD) and of aging. Furthermore, 4-HNE and 4-HHE, despite their chemical 
similarity, modify different sites, introducing the concept that each oxidation event 
may initiate distinct signaling outcomes. Finally, we evaluate the functional role of 
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histone carbonylation by investigating the genomic localization of carbonylation 
events in comparison to transcriptional outcomes. Together, this work suggests 
that histone carbonylation is an abundant epigenomic modification that is a 
critical link between oxidative stress and metabolic dysfunction in adipose tissue.  
 
 
Materials and Methods 
Animals 
 
Wild-type C57Bl/6J mice were weaned at 3 weeks of age and then fed either a 
high fat diet (20% protein, 35.5% fat, 36.3% carbohydrate; BioServ F3282) or a 
chow diet for 12 weeks. Ob/ob mice were obtained at 10 weeks and maintained 
on chow diet for two weeks prior to sacrifice. Animals were sacrificed by cervical 
dislocation and epididymal and inguinal white adipose depots were removed for 
analysis. Experiments were carried out were approved by the University of 
Minnesota Institutional Animal Care and Use Committee. For the Aging 
experiment, eWAT tissues were obtained from Yuxiang Sun (Texas A&M 
University). 
Drosophila melanogaster flies (yw WT strain) were reared on standard agar-
cornmeal medium at 25°C under a 12:12 h light/dark cycle. Male and female flies 
were collected within 24-hours of eclosion and housed separately (50-60 flies per 
vial). Flies were counted and transferred to new vials every two days for the 
duration of the experiment. At the appropriate time points, flies were collected, 
snap-frozen in liquid nitrogen, and stored at -80°C until processing. 
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Cell Culture 
3T3-L1 fibroblasts were grown to confluence and differentiated as previously 
described108 using the standard differentiation cocktail consisting of 
dexamethasone, methylisobutylxanthine, and insulin. On day 7 of differentiation, 
cells were treated with 10 uM erastin (Cayman Chemical 177754) or vehicle 
(DMSO) in DMEM +5%FBS for 24 hours before harvesting. 
 
Histone Preparation 
From mice, fresh tissue was minced on ice in hypotonic lysis buffer (10 mM Tris-
Cl pH 8.0, 1 mM KCl, 1.5 mM MgCl2, 1mM DTT) with protease and phosphatase 
inhibitors. Tissue was homogenized with a glass-Teflon system using an electric 
homogenizer (8 strokes, 1600 rpm). Samples were spun at 1000 rpm at 4°C for 
10 minutes and the fat cake was discarded. Then, samples were briefly vortexed 
and spun at 3700 rpm at 4°C for 10 minutes to collect nuclei. Histones were 
purified using acid extraction, reduced in 15mM NaBH4, and quantitated using the 
BCA assay (Sigma Aldrich). Where indicated, histones were salt-purified using 
the method described by Schecter et, al.153 
From flies, frozen pellets were ground using mortar/pestle in hypotonic lysis 
buffer supplemented with 1% NP40 and .1% SDS. Insoluble debris was cleared 
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and nuclei were collected by centrifugation. Histones were prepared as described 
above. 
 
 
Western blotting analysis 
Samples were prepared for western blot by mixing normalized samples with 4X 
loading buffer. Samples were resolved by SDS-PAGE, wet transferred to 
nitrocellulose membrane, blocked for 1 hour with blocking buffer (LI-COR 927-
4000) and incubated with primary antibodies overnight at 1:1000 dilutions in 
TBS-T + 5% BSA. Membranes were then washed 3X in TBS-T and incubated for 
1 hour with fluorescently labeled secondary antibodies (LI-COR) and imaged 
using the LI-COR Odyssey Imager. Antibodies used include 4-HNE (Millipore, 
393207), 4-HHE (non-commercial), Histone H3 (abcam 10799), and Histone H4 
(Cell Signaling 2935S). 
 
In vitro modification of purified histones 
Acid extracted histones were resuspended in Adduction Buffer (100 mM 
potassium phosphate pH 7.4, 150 mM NaCl). Samples were then incubated at 
37°C with the indicated concentrations of 4-HNE (Cayman Chemical 32100)	  and 
4-HHE (Cayman Chemical 32060). Reaction was quenched with 5 mM DTT. 
Modification was verified by western blotting.	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Chromatin and Nucleoplasm Separation 
Cells were washed 3X with PBS and lysed in hypotonic lysis buffer (10 mM Tris-
Cl pH 8.0, 1 mM KCl, 1.5 mM MgCl2, 1mM DTT) with protease and phosphatase 
inhibitors. Nuclei were collected by centrifugation (10 minutes, 10,000 rpm at 
4°C) and washed 2X with hypotonic lysis buffer. Nuclei were then resuspended in 
low salt buffer (10 mM Tris-Cl pH 7.4, .2 mM MgCl2, 1% Triton X-100, protease & 
phosphatase inhibitors) and incubated on ice for 15 minutes. Samples were spun 
at 14,000 rpm for 10 minutes at 4°C. The supernatant (nucleoplasmic fraction) 
was collected and concentrated prior to analysis. The pellet (chromatin fraction) 
was resuspended directly into 1X loading buffer. The entire sample for each 
fraction loaded into each lane and resolved by SDS-PAGE into order to 
appropriately compare histone content.  
 
Immunoprecipitation of carbonylated proteins  
For IP of proteins, 10-20 ug of reduced, purified histones were diluted to 500 ul 
with a PBS+ 1% NP40 and then pre-cleared with protein A/G agarose resin (Sant 
Cruz sc-2004). 4-HNE primary antibody (Millipore 393207) was cross-linked to 
protein A/G agarose resin using DMP imidoester crosslinking reagent (Thermo 
Scientific) according to manufacturer’s instructions. Cross-linked antibody/resin 
was incubated with histones overnight. The next day, resin was washed 3X with 
RIPA buffer and proteins were eluted by boiling in 4X DNS. Samples were 
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resolved by SDS-PAGE and stained with Imperial Protein Stain (Thermo 
Scientific) prior to in gel digestion.  
 
 
 
In gel digestion 
SDS-PAGE gel bands (H1,H2A/B &3, H4) were first washed by 50% EtOH in 
water for overnight and then washed by water for an hour. Each gel band was cut 
into small pieces and then dehydrated by acetonitrile. Proteins were reduced and 
alkylated at room temperature in dark by TCEP (15 mM) and iodoacetimide (45 
mM) in PBS. Then the gel pieces were washed sequentially by 50 mM ammonia 
bicarbonate, 100% acetonitrile, and dried completely by SpeedVac 
(ThermoFisher). Trypsin stock solution (Promega) was reconstituted in 50 mM 
ammonia bicarbonate buffer to 10 ng/µl and applied to digest proteins in-gel for 
overnight at 37 °C. Peptides were extracted sequentially by Extraction Buffer (5% 
trifluoroacetic acid and 50% acetonitrile in water, v/v) and 100% acetonitrile. The 
pooled peptide extracts were dried in SpeedVac and then desalted by C18 
Stagetip as previously described.109  
 
LC-MS/MS 
Peptides were reconstituted in HPLC buffer A (0.1% formic acid in water, v/v) 
and injected into a Proxeon Easy nLC 1000 HPLC system (ThermoFisher) by 
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autosampler. Peptides were separated by C18 column packed in-house (15 cm × 
75 µm, ReproSil-Pur Basic C18, 2.5 µm, Dr. Maisch GmbH) with a linear gradient 
of 5%-35% HPLC buffer B (0.1% formic acid in acetonitrile, v/v) at a flow rate of 
200 nl/min. Eluted peptides were directly electrosprayed into the Fusion Orbitrap 
mass spectrometry (ThermoFisher). The instrument was operated in a data-
dependent mode with full mass spectra were acquired with a resolution of 
120,000 FWHM at 200 m/z and MS/MS spectra were acquired using collision-
induced dissociation (CID) with 35% collision energy for detection in the ion trap. 
 
MS data processing 
Raw MS data were processed by MaxQuant software (v 1.5.3.12) for protein 
identification.110 Variable modifications include carbamidomethylation on cysteine 
and lysine, methionine oxidation, protein N-terminal acetylation, HNE and 
reduced HNE on cysteine, histidine and lysine, as well as HHE and reduced HHE 
on cysteine, histidine and lysine. Trypsin was selected as the proteolytic enzyme 
and a maximum of two missing cleavages were allowed. The precursor ion mass 
tolerance was set to +/-4.5 ppm and the fragment ion mass tolerance was set to 
+/-0.6 Da. MS data were searched against the Uniprot mouse database 
(released on 2013/09/27 and containing 43310 sequences).  Peptides were 
filtered with a 1% False Discovery Rate (FDR) at the peptide, protein and 
modification site levels.  A minimum Andromeda score of 40 was required for the 
identification of modified peptides. 
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Preparation of sheared chromatin 
3T3-L1 cells were grown in 10 cm plates, differentiated according to normal 
protocol and treated on day 7 with erastin (Cayman Chemical 177754) or vehicle 
(DMSO). Cells were washed 2X with ice cold PBS. Cells were harvested by 
scraping into .5 mL of lysis buffer (0.1% SDS, 1% Triton X-100, .15 M NaCl, 1 
mM EDTA, 20 mM Tris pH 8) and incubated on ice for 30 minutes. Cells were 
homogenized on ice with 10 strokes using a glass manual homogenization 
system. Nuclei were collected by centrifugation for 10 minutes at 5000 rpm at 
4°C. Nuclei pellets were resuspended in 15 mM NaBH4 and incubated at RT for 
20 minutes for aldehyde reduction. Nuclei were collected by centrifugation and 
washed 3X with PBS. Chromatin was sheared enzymatically using the ChIP-IT 
Express Enzymatic Shearing Kit (Active Motif 53035) according to 
manufacturer’s instruction. The shearing reaction was incubated at 37°C for 10 
min with vortexing every two minutes. The reaction was stopped with EDTA and 
incubated on ice for 10 minutes. Insoluble material was cleared by centrifugation 
and chromatin was stored at -80°C until it was used for ChIP experiments. 
 
ChIP-PCR and ChIP-seq 
Sheared chromatin was immunoprecipitated with antibodies for 4-HNE (Millipore, 
393207), H3 (abcam 1791), H3K27me3 (Active Motif 39156), H3K4me3 (abcam 
8580), rabbit IgG (abcam, 171870). Protein A Dynabeads (novex 100001D) were 
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used to magnetically capture immune complexes. Samples were then eluted with 
1% SDS and .1M NaHCO3 followed by DNA precipitation.  
For ChIP-seq, ChIP was carried out independently for 6 samples each of erastin- 
and vehicle-treated cells. 3 ChIP reactions were pooled together for each 
condition prior to library preparation and sequencing. Library preparation 
(Thruplex ChIPseq libraries) and deep sequencing (HiSeq 2500, 50-bp single 
read) was carried out at the University of Minnesota Genomics Core. 
For ChIP-PCR, the immunoprecipitated DNA and input DNA amplified using a 
Bio-Rad iCycler thermocycler with iQ SYBR Green Supermix. Control primers for 
a gene desert on chromosome 6, Pax-2, and Actb-1 were purchased from Active 
Motif (71011,71020, 71015).  All other primers are listed in Table 1. 
 
Table 1.  q-RT-PCR primer pairs 
 
Results 
The core histones are carbonylated in vitro and in vivo  
Recent work from the Bernlohr lab demonstrated that protein carbonylation is 
elevated in the nucleus of adipocytes in from obese animals compared to lean 
controls. In agreement with this data, Figure 1A shows that nuclear carbonylation 
is markedly increased as a consequence of high fat diet feeding. Previously, 
Gene Primer Sequence 
Nrf2A fwd CGAGCATATCTCCTAGT 
Nrf2A rev CTACTTGCAGAGGTGAG 
Ndufa2 fwd CACTACGCACTACGCAACTA 
Ndufa2 rev GCCTCTCTTTTAGGGACGTG 
Mfn2 fwd TCCCTTTGAAGACACTCGGA 
Mfn2 rev ACGACAAGGGTACCGATTAG 
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studies have shown that visceral adipose depots exhibit a strong oxidative stress 
phenotype in obese mice and humans, while subcutaneous depots do not61. 
Consistent with these data, the elevation in carbonylation in obese mice is 
specific to epididymal depots (eWAT) and is not observed in the inguinal depot 
(iWAT) (Figure 1A).  
 
The core histones are relatively small proteins (10-15 kDa) and are among the 
most abundant proteins in the nucleus. Analysis of nuclear of protein 
carbonylation by western blot left us intrigued about the low Mr carbonylated 
proteins, hypothesizing that the core histones are targets of 4-HNE modification 
in obese eWAT (Figure 1A). To test this, we purified histones by acid extraction 
from eWAT and iWAT depots of lean and obese mice. We observed a significant 
increase in 4-HNE adducts on all core histones from eWAT depots of HFD-fed 
mice compared to lean controls (Figure 1B, 1D). To rule out diet-specific effects, 
we performed the same analysis with wild type (WT) and ob/ob mice. The Ob/ob 
mouse model is a well-characterized genetic model of obesity in which the mice 
are fed the same chow diet as controls but become obese due to an extreme 
increase in caloric intake154,155.  Ob/ob mice exhibited a similar increase in 
histone carbonylation in eWAT but not in iWAT, indicating that histone 
carbonylation is not an artifact of the HFD but is the result of increased adiposity 
(Figure 1C, 1E).  
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To assess the relative stoichiometry of 4-HNE modification, we purified histones 
and from eWAT and subsequently immunoprecipitated 4-HNE Michael adducts. 
Roughly 33% of the total histone pool was present in the IP fraction compared to 
the unmodified (supernatant) fraction, indicating that 4-HNE modification occurs 
a significant population of total histones in eWAT. 
 
To investigate histone modification further, we turned to models of oxidative 
stress in cultured cells. In 3T3-L1 adipocytes, treatment of cells with inflammatory 
cytokine TNF-α, knockdown of key antioxidant glutathione-S-transferase A4 
(GSTA4), and treatment with erastin, which leads to depletion of intracellular 
glutathione121, all result in elevated 4-HNE modification of histones 
(Supplementary figure 1A-C). Together these data indicate that histone 
carbonylation is a dynamic redox sensitive modification that occurs in adipocytes 
in vivo.  
 
We next wondered whether 4-HNE modification was occurring primarily on 
chromatin-associated histones or free histones. To test this, we isolated 
chromatin and nucleoplasm fractions of eWAT from mice fed a HFD. We could 
not detect a significant pool of free core histones, modified or unmodified in the 
nucleoplasm, suggesting that histone carbonylation is primarily occurring on 
chromatinized histones in adipocytes.  
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Figure 1.  4-HNE modification of histones occurs in vivo and is increased in 
obese animals 
(A) 4-HNE modification in crude nuclear extracts from high-fat (HFD) and chow-
fed mice in eWAT and iWAT. 
(B) 4-HNE modification of histones purified from eWAT and iWAT of HFD and 
chow mice 
(C) 4-HNE modification of histones purified from eWAT and iWAT of WT and 
Ob/Ob mice 
(D,E) Quantitation of (B,C, respectively). Relative level 4-HNE modification in 
obese mice relative to lean controls. Normalized to histone H4. P <.05. 
(G) Chromatin and nucleoplasm fraction of eWAT from HFD-fed mice. 
(F) Immunoprecipitation of histones with 4-HNE modifications (IP:4-HNE) and an 
IgG isotype control IP (IP:IgG). Sup+wash (lanes 4-5) refer to all proteins 
remaining in the supernatant following IP plus proteins in the first two wash steps 
following IP. 
 
 
Histone carbonylation accumulates in aged flies and mice 
The observation that histone carbonylation is induced in models of obesity led us 
to wonder if these modifications are unique to the obesity phenotype. As such, 
we set out to test other models in which oxidative stress plays a defining role. 
Aging is a complex process that involves many different metabolic perturbations, 
one of which is elevated oxidative stress156. Several studies demonstrate the 
age-dependent increase in ROS and ROS-related damage including modification 
of proteins by lipid electrophiles157-159. As such, we decided to test whether aging 
led to an accumulation of 4-HNE modified histones. To test this, we aged WT 
male and female (yw/yw) drosophila melanogaster flies for 8 weeks and 
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assessed the level of 4-HNE modification of histones from whole animals at 
0,2,4,6,and 8 weeks (Figure 2A). No change was detectable in female flies at any 
point over the course of 8 weeks (Figure 2B, 2D), but male flies showed a 
significant increase in the modification of all core histones at 6 weeks (Figure 2C, 
2E). Interestingly, modification of histone H4 displayed the most significant 
increase starting at 2 weeks of age (Figure 2C, 2E). 
Consistent with this, in male mice aged 3,6,12,and 18 months, there was a 
significant increase in the level of histone modification beginning at 12 months 
(Figure 2F, 2G). Together, these data provide evidence that 4-HNE modification 
of histones is an evolutionarily conserved process that increases as a 
consequence of age. 
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Figure 2: Histone carbonylation is increased with aging in mice and flies 
 
(A) Survival curve of flies over the course of 8 weeks. Total percent of surviving 
male and female flies during each experimental week. 
(B,D) 4-HNE modification of histones purified from total fly homogenate for 
females (B) and males(D) 
(C,E) Quantitation of histone carbonylation in female (C) and male (E) aged flies 
compared to newly hatched flies (week 0). Normalized to coomassie stain, 
significance is set at P<.05. 
(F) 4-HNE modification of histones purified from eWAT of mice aged 3-18 
months. 
(G) Quantitation of (F). Normalized to coomassie, significance is set at P<.05. 
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Proteomic analysis of histone carbonylation sites in vitro 
We next sought to identify specific sites of histone modification by 4-HNE. 
Recently, our lab developed a technique to perform label-free proteomic analysis 
of protein carbonylation (unpublished data). Here, we adapted this method to 
study histone modifications.  First, we generated a positive control by in vitro 
modifying histones purified from WT-3T3-L1 fibroblasts. In vitro modification led 
to the robust modification of all core histones (Figure 3A, 3B). Modification for all 
histones occurred at the same rate, indicating that in vitro, there is not a 
detectable site preference for 4-HNE modification (Figure 3A). Proteomic 
analysis of the positive control revealed sites on all four core histones (Figure 
3D). 4-HNE modification of proteins can occur as either a Michael adduct on 
lysine, histidines, and cysteines or as a Schiff base on lysine residues (Figure 
3C). We detected both types of adducts on all core histones, but the majority of 
identified sites were Michael adducts (Figure 3E). This data is consistent with 
previous work that indicates that Schiff bases are more labile in nature, while 
Michael adducts are stable.  
 
The core histone proteins share in common the basic structure of a C-terminal 
globular histone fold domain and an N-terminal, unstructured, lysine-rich tail. The 
lysine residues of the histone tail have been the subject of intense study due to 
their role in replication and transcriptional regulation. Interestingly, over 90% of 
the sites identified in this study mapped to the globular histone-fold domain rather 
  114 
than the N-terminal lysine-rich tail (Figure 3F, 3G, Supplementary Table 1). 
Modifications were identified on all faces of the nucleosome, including residues 
involved in histone-histone interaction, nucleosome-DNA interaction on the 
lateral surface, and solute accessible surfaces (Figure 3F-H). In sum, these data 
show that histones are robustly modified by 4-HNE in vitro and these 
modifications are readily detectable using the described methodology. 
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Figure 3: Proteomic evaluation of 4-HNE adducts on in vitro modified core 
histones 
(A) In vitro modification of purified histones with 4-HNE. Titration of 4-HNE 
concentration (left) and reaction time (right). 
(B) Flow diagram of LC-MS/MS workflow for proteomic analysis of modified sites. 
(C) Nucleophilic attack of 4-HNE by the side chains of Cys, His, and Lys can 
result in Michael adduct formation or Schiff base formation. 
(D) Distribution of identified sites on the core histones 
(E) Percentage of Michael adducts and Schiff bases identified in this screen. 
(F,G) Ribbon diagram of the nucleosome. Front (F) and Side (G) view. Sites of 
modification are in yellow. 
(H) Depiction of the localization of identified sites on the nucleosome structure. 
 
Proteomic analysis of in vivo histone carbonylation sites 
We next investigated sites of protein carbonylation in vivo. To do this, we 
performed analysis of samples using an unbiased approach in which total 
histones were purified from eWAT and resolved by SDS-PAGE prior to in gel-
digestion and LC-MS/MS (Figure 4A). We also utilized an enrichment approach 
whereby 4-HNE-modifed proteins were immunoprecipitated from the total histone 
pool prior to SDS-PAGE (Figure 4A). Together, these studies led to the 
identification of 21 histone modifications including 14 sites on the core histones 
and 7 sites on linker histone H1 (Figure 4B, Supplementary Table 1). Of these, 
20 are novels sites. H2BK117 has previously been reported as 4-oxononenal (4-
ONE) target site in in-vitro modified cells160.  
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In contrast to the in vitro modified histones, we observed 7 sites localized to the 
N-terminal histone tail including critical regulatory sites H3K4, H3K9, H3K36 and 
H2BK5. Interestingly, there were no overlapping sites identified between 4-HNE 
and 4-HHE modifications.  
We next tested the relative abundance of these modifications in lean vs. obese 
eWAT. Only four sites were identified in both lean and obese samples. Of these, 
we observed elevated stoichiometry of modification in obese relative to lean 
controls for H2AK734-HHE, H2AK1254-HHE, and H4K314-HNE (Figure 4C, 
Supplementary table 2). 
 
Interestingly, the 4-HHE sites were all located within the C-terminal histone fold 
domain while the 4-HNE modifications were localized primarily to the N-terminal 
histone tail (Figure 4B). Consistent with these data, analysis of histones from WT 
and ob/ob mice by western blot indicates that 4-HNE modification is more heavily 
localized to H3 and H4, while 4-HHE is predominately on H2A/B and H4 (Figure 
4D). Moreover, treatment of 3T3-L1 adipocytes with either 4-HNE or 4-HHE 
results in distinct carbonylation signatures of the core histones (Figure 4E). This 
is in contrast to purified histones modified in vitro (Figure 4E). Together these 
data suggest a previously unappreciated specificity for 4-HNE vs. 4-HHE 
modifications. 
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Figure 4: Identification of carbonylation sites in vivo 
(A) Proteomic workflow for identification of sites. Both unenriched and 
immunoaffinity enrichment for 4-HNE modified histones were resolved by SDS-
PAGE, in gel digested, and analyzed by LC-MS/MS. 
(B) Cartoon diagram of the sites identified in this screen. Both 4-HHE adducts 
and 4-HNE adducts were identified. 
(C) Relative abundance of carbonylation events identified in eWAT from both 
lean and obese mice. Values represent the peak width of the identified site 
normalized to the abundance of each protein detected in individual samples. 
(D) 4-HHE and 4-HNE modification of histones from eWAT for WT and ob/ob 
mice. 
(E) In vitro modification of purified histones with 4-HNE (upper panel) and 4-HHE 
(lower panel), lanes 1-4. Treatment of 3T3-L1 adipocytes with 4-HNE and 4-HHE 
(lanes 5-8).  
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ChIP-seq of 4-HNE modified sites (currently underway) 
Histones are essential regulators of chromatin structure and organization and the 
dynamic post-translational modification of histones is responsible for 
orchestrating gene expression in every human cell type. The identification of 
carbonylation sites on known regulatory residues led us to hypothesize that 
carbonylation of these site would impact transcriptional outcomes in adipose 
tissue. 
 
To investigate this potential functional role of histone carbonylation, we first set 
out to determine the genomic localization of the modifications by chromatin 
immunoprecipitation followed by deep sequencing (ChIP-seq). The workflow we 
used differs from traditional ChIP in several important ways (Figure 5A). First, we 
did not include a crosslinking step. Recent work from our lab demonstrated that 
many chromatin-associated proteins are carbonylated. Crosslinking would result 
in the capture and eventual IP of any non-histone carbonylation targets. Due to 
the lack of a crosslinking step, a more gentle shearing protocol was essential for 
maintenance of nucleosome-DNA complexes. As such, we utilized micrococcal 
nuclease digestion for DNA shearing followed by chromatin immunoprecipitation. 
Analysis of sheared DNA by agarose gel electrophoresis indicates that this 
strategy results in appropriately sheared mono- and di-nucleosome fragments 
(Figure 5B). 
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For this initial study, we utilized 3T3-L1 adipocytes treated with vehicle (DMSO) 
or pro-oxidant erastin. For each sample we carried out ChIP for 4-HNE adducts, 
histone H3, H3K4me3, H3K27me3, and IgG isotype control (Figure 5A). H3K4me3 
and H3K27me3 are modifications that have been extensively studied and are 
markers for active and repressed chromatin, respectively. Comparison of ChIP 
peaks for 4-HNE with these marks will be informative as to the chromatin 
landscape surrounding carbonylation sites. To ensure the quality of ChIP-DNA 
we analyzed samples by q-RT-PCR. Generally, PCR targets are chosen that are 
expected to be enriched (or serve as a negative control) for a given sample. 
Since there are no known targets of 4-HNE modification, we are unable to 
assess the ChIP with q-RT-PCR. However, we did perform this analysis with 
ChIP-DNA from IgG, H3K4me3 and H3K27me3.  
 
As expected, H3K4me3 was enriched at Actb, Nrf2, Mfn2, and Ndufa2 but not at 
a gene dessert on chromosome 6 (Chr6D). Likewise, H3K27me3  was enriched at 
Pax2 and Chr6D, both loci that are not actively expressed in 3T3-L1 adipocytes. 
Interestingly, both erastin treatment and 4-HNE treatment of 3T3-L1’s led to a 
decrease in H3K4me3  at Nrf2, Mfn2, and Ndufa2 compared with control cells 
(Figure 5C). These are genes encoding mitochondrial proteins that are known to 
be down regulated in obesity, and these observations indicate that oxidative 
challenge to adipocytes results in an altered chromatin state with loss of the 
activating H3K4me3 mark. 
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Library preparation and barcoding was performed using ThruPLEX chemistry at 
the University of Minnesota Genomics Core followed by deep sequencing on the 
Illumina HiSeq 2500 sequencer on 50-bp single-read run. 24-39 million 
unmapped reads were generated for each sample (Figure 5E). The ongoing 
analysis of this data will provide novel insights into the functional significance of 
the modifications identified in this study. 
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Figure 5. Functional analysis of histone carbonylation with ChIP-seq 
(A) Basic workflow for preparation of ChIP-DNA from control (DMSO) and 
erastin-treated 3T3-L1 adipocytes 
(B) Agarose gel of DNA fragments precipitated after enzymatic shearing with 
MNase. 
(C,D) ChIP-PCR of H3K4me3 (left) and H3K27me3 ChIP’d DNA from control 
(DMSO), erastin, and 4-HNE treated 3T3-L1 adipoctyes. Y axis indicates 
enrichment over IgG isotype control ChIP. 
(E) Number of unmapped reads generated for each sample. Samples were run 
on a HiSeq 2500, 50-bp single read run. 
B 
La
dd
er
 (b
p)
 
NT
 (5
 ul
) 
NT
(1
0 u
l) 
ER
 (5
 ul
) 
ER
 (1
0 u
l) 
100 
300 
500 
Mono-nucleosome 
Di-nucleosome 
1000 
2000 
0 
5000 
10000 
15000 
20000 
25000 
Pa
x2
 
Ac
tb1
 
Nr
f2A
 
Mf
n2
 
ND
UF
A2
 
Ch
r6.
 
Fo
ld
 E
nr
ic
hm
en
t o
ve
r I
gG
 
H3K4me3 ChIP 
Vehicle 
Erastin 
4-HNE 
0 
400 
800 
1200 
1600 
2000 
Pa
x2
 
Ac
tb 
Nr
f2 
Mf
n2
 
Nd
ufa
2 
Ch
r6.
 N
on
ge
nic
 
Fo
ld
 E
nr
ic
hm
en
t o
ve
r I
gG
 
H3K27me3 ChIP 
 
4  
8  
12  
16  
2  
 
Ac
tb 
Nr
f2 f
 
Nd
ufa
 
Ch
r6.
 N
on
ge
nic
 
Fo
ld
 E
nr
ic
hm
en
t o
ve
r I
gG
 
3K27me3 ChIP 
C D 
0.0E+00 1.0E+07 2.0E+07 3.0E+07 4.0E+07 
E2_HNE 
C1_IgG 
C2_HNE 
E1_HNE 
C2_IgG 
C2_H3 
C1_K4 
C1_HNE 
E1_IgG 
C1_H3 
E1_K4 
E2_IgG 
C2_K4 
E2_H3 
E1_H3 
E2_K27 
E2_K4 
C1_K27 
E1_K27 
C2_K27 
Number of reads/sample 
E 
  125 
 
 
Supplementary Figure 1. Oxidative stress induces histone modification in 
cultured models of oxidative stress in adipocytes 
 
(A) 3T3-L1 adipocytes treated with .5nM TNF-α on day 8 of differentiation for 4,8, 
and 12 hours. 4-HNE (upper) and 4-HHE (lower) modifications on purified 
histones. 
(B) 4-HNE adducts on histones from Scr control and GSTA4 knockdown cells. 
(C) 4-HNE adducts on histones from cells treated with DMSO (no treatment) or 
15 µM erastin for 24 hours.  
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Table 2.  Histone carbonylation sites identified in eWAT from HFD-fed mice 
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Table 3. Stoichiometric comparison of sites identified in both lean and 
obese eWAT 
 
 
 
 
 
Discussion 
The molecular and mechanistic linkage between environmental queues and 
metabolic disease and aging is complex and likely brought about by a 
combination of hormonal, metabolic and genetic determinants162-165.  A common 
theme in many metabolic diseases is oxidative stress and downstream events 
linked to redox biology143,166. Here we examine the role of one such redox event-- 
protein carbonylation-the covalent modification of proteins with reactive lipid 
aldehydes and its primary detoxification enzyme, Gsta4, as a major regulatory 
mechanism linking mitochondrial oxidative stress to the epigenome.  
 
In this study, we show that the core histones are differentially modified by 
reactive lipid species 4-HNE and 4-HHE in obese white adipose depots. 
Furthermore, we show that these modifications are elevated in WAT as a 
consequence of age. These effects are specific to epididymal depots, where 
previous work demonstrates a significant down regulation of Gsta4 in obesity61. 
Histone Site Peptide Peak Area (High Fat) 
Peak Area 
(Low Fat) 
Protein ratio for 
normalization Ratio (HF/LF) 
H1.1 K86 LVNK(hhe)GTLVQTK 2691238 3208132 0.74 1.14 
H1.3 K173 KKVSK(hhe)SPK 10179121 40458608 0.74 0.34 
H2A K125 KTESH(hhe)K(hhe)SQT 31146776 11591858 0.37 7.31 
H2A K73 DNKK(hhe)ARIA 81172464 13417783 0.37 16.46 
H4 K31 DNIQGITK(rehne)PAIR 5669262 761061 4.54 1.64 
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Furthermore, it is interesting to note that carbonylation was not elevated in aged 
female flies while there was a significant increase in males. It is well documented 
that women have a longer life expectancy than males167. This has been attributed 
to a variety of factors, but it has been demonstrated that females generally 
express higher levels of antioxidants and therefore have less ROS productions 
than males168. This effect likely mitigates the deleterious effects of ROS and 
prevents modification of histones in females during the aging process. 
 
Importantly, one other recent study has also indicated that histone proteins are 
susceptible to this type of modification160. In that study, RKO cells were treated 
with exogenous 4-HNE and 4-ONE. This resulted in robust modification of 
histones and the identification of several sites by LC-MS/MS. Our study expands 
upon these findings to demonstrate that histones modification occurs in vivo. 
 
The epigenome is operationally defined by a complex and highly regulated series 
of biochemical modifications focused on the covalent modification of DNA or 
DNA binding proteins (largely histones)169-171. Such modifications lead to the 
recruitment and assembly of transcription factors and DNA binding proteins 
affecting either activation or repression of nearby genes. Indeed, while histone 
modification by methylation and acetylation are widespread and function in the 
control of chromatin organization and transcription, expanded analysis advanced 
via proteomic technology has revealed a series of additional modifications whose 
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role(s) are less widely understood169,172. 
 
In this study, we identify 14 novel epigenomic modifications including critical 
regulatory sites H3K4HNE, H3K9HNE, H3K36HNE, H4K31HNE, and H3K56HHE. The 
breadth of sites found in this study and their importance in the regulation 
transcription underlie the functional importance of these findings. For example, 
H3K4me3 is a canonical activating mark173 that is estimated to be present on up 
to 75% of human gene promoters174,175. In contrast, H3K9me3 is a strongly 
repressive mark when localized to promoter regions176. These modifications are 
dynamic and highly regulated by specific methyltransferases and demethylases. 
Importantly, the carbonylation of lysine residues via a Michael addition reaction is 
a covalent modification for which there are currently no known removing 
enzymes. This is critical for it implies that histone carbonylation is a stable 
epigenomic mark that persists under a variety of metabolic conditions until the 
histone protein itself is degraded. Moreover, since the reaction is non-reversible, 
it negates target sites from subsequent modification and further epigenomic 
control, potentially leading to prolonged impact on transcriptional regulatory 
mechanisms. 
 
The next phase of this project will be particularly informative, as identification of 
genomic sites of protein carbonylation combined with expression analysis will 
shed light on the specific role of this type of event. Moreover, it is unclear if 
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histone carbonylation is in some way targeted to sites in the genome. These 
studies will allow us to examine if histone carbonylation is a random and global 
type of damage that occurs or whether it accumulates in certain chromatin 
landscapes. Finally, the differences in 4-HHE and 4-HNE modification is striking- 
both in western blots and by proteomic evaluation of the sites modified. It is 
unclear why or how this selectivity occurs, particularly as carbonylation is a 
chemically driven process. These observations suggest that there is an 
unappreciated regulatory mechanism that directs these modifications.  
 
Oxidative stress is a hallmark of metabolic dysfunction and understanding the 
mechanisms by which it contributes to metabolic disease is an important goal. In 
this study, we introduce a novel concept in regulatory biology that extends work 
on mitochondrial oxidative stress and protein carbonylation to epigenomic 
regulation of transcription in adipose tissue. 
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As the global incidence of metabolic disease continues to rise, the importance of 
understanding and defining how to maintain metabolic homeostasis in the face of 
environmental stressors becomes increasingly evident. While metabolic 
perturbation takes on distinct phenotypes depending on the tissue and type of 
stress, one thing shared in common is an altered cellular redox environment. As 
such, study of the redox mechanisms that define the metabolic state of a cell 
type or tissue is a necessary step in the pursuit of understanding metabolic 
changes during health and disease. 
The work described here addressed this problem through the study of protein 
carbonylation in adipose tissue. We found that the post-translational modification 
of proteins by 4-HNE and 4-HHE  were highly enriched in the nucleus of the 
adipocyte in the obese state. This observation led to interest in development of a 
proteomic method to identify the sites of modification. We designed the method 
with the goal of being able to determine a comprehensive lipid modification map 
that would allow for identification not only of the proteins modified, but also the 
residues and the specific lipid species. Collaboration with the laboratory of Dr. 
Yue Chen led to the successful use of affinity purification followed by LC-MS/MS 
to identify many novel targets.  
This technological innovation enabled the focused study of 4-HNE and 4-HHE 
modified proteins that led to several important observations. First, zinc-
coordinating residues are hotspots for lipid electrophile adduction. This finding 
has important implications for several reasons; zinc ions stabilize protein 
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structure and their coordination requires unmodified thiols133. As such, 
permanent modification of coordinating residues will result in the release of the 
zinc ion and likely have a large impact on protein structure and stability. In 
addition, in the nucleus there are many zinc finger proteins and these are 
essential for sequence-specific DNA binding129. As an example, we have 
highlighted the estrogen-related receptor family of nuclear receptors and shown 
that carbonylation of the zinc finger within the DNA binding domain results in 
complete inhibition of DNA binding. It is likely that modification of the other zinc-
finger proteins identified in these studies would result in similar effects and future 
study of the biological implications of those modifications will be important. 
A second major finding of this work is that histones are dynamically modified by 
4-HNE and 4-HHE in conditions of oxidative stress. In particular, the identification 
of histone-tail residues as carbonylation targets has spurred our interest in 
defining a functional role for these modifications. We generally hypothesize that 
histone carbonylation will disrupt normal regulatory mechanisms that govern 
transcription outcomes in adipose; if a lysine is carbonylated, it cannot be 
acetylated or methylated. Thus far, it is difficult to predict the specific 
transcriptional effect (up regulation vs. down regulation) these modifications will 
incur, though I hypothesize that the permanent addition of a nine-carbon or 6-
carbon lipid to lysine residues will result in the interruption of DNA-nucleosome 
contact much in the same way that lysine acetylation has been shown to do.  
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To address these questions, we have initiated the first ever ChIP-seq experiment 
for 4-HNE modified histones. While this work is still underway, it will inform us as 
to the genomic localization of the modifications and what type of chromatin 
environment it occurs in. Major questions that we hope to answer include 
whether or not the modification is specific to active or repressed chromatin (or if it 
occurring randomly throughout the genome). In addition, we plan to evaluate 
expression of genes in close proximity to peaks identified in the ChIP-seq 
experiment to correlate protein carbonylation to the regulation of gene 
expression.  
Finally, we have begun the process of generating site-specific antibodies directed 
against several of the histone modifications that we identified. These antibodies 
will be a unique and exceptional tool to evaluate the functional role of specific 
modifications. Moreover, to our knowledge, these will be the first example of a 
tool to investigate single sites of modification. It will be very exciting to 
biochemically interrogate histone carbonylation with this new resource. 
In addition to the experiments described above that stem neatly from these 
studies, there are several more biological questions that this work has 
precipitated that will be interesting and informative pursuits in the future: 
 
Site of ROS production and reactive lipid formation 
The observation that the nucleus is a major site for protein carbonylation was 
unexpected. For many years the mitochondrion has been the focus of oxidative 
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stress studies. This is for good reason, because while there are many sources of 
intracellular ROS, the mitochondria remains a major and prominent source177. 
Now, a key question to be answered is what the source of ROS is for nuclear 
protein carbonylation. It is possible that the lipids are formed inside of the 
mitochondria and diffuse to the nucleus, but this is hard to justify with the lack of 
differential carbonylation of the cytoplasmic fraction in lean vs. obese eWAT. 
Another possibility is that the lipids form outside of the mitochondria, potentially in 
the endoplasmic reticulum (ER), which is another ROS-rich microenvironment. 
Finally, it could be that the lipids are formed in the nucleus itself, though it is 
unclear what the source of ROS might be in this case. Potential experiments to 
address this question might include fluorescent tracking of various ROS 
intermediates upon oxidative stimuli of cultured cells. In addition, cells can be 
treated with organelle-specific ROS-inducing compounds (for example, Antimycin 
A for mitochondrial ROS and tunicamycin for ER ROS). Analysis of carbonylation 
patterns by confocal microscopy following these treatments could shed light as to 
the most likely source of ROS.  Furthermore, careful fractionation followed by 
biochemical evaluation of lipid species could help determine whether free 
reactive lipid aldehydes are increased in the nucleus relative to other cellular 
compartments. 
 
The site of reactive lipid formation has important implications for another reason: 
these lipids are generated through the damage of poly-unsaturated fatty acids in 
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lipid membranes. Something that is underappreciated about this is that when 4-
HNE and other free aldehydes are cleaved from phospholipids, it leaves behind a 
damaged lipid in the membrane142. Elegant work has shown that the presence of 
these oxidized lipids can have profound effects on membrane dynamics, 
particularly in the mitochondria178. Since reactive lipid aldehydes are readily 
formed in adipocytes under oxidative stress, it follows that there is also significant 
damage to phospholipids and membrane structures. As such, a better 
understanding of the source of reactive lipid aldehydes in the adipocyte is an 
important and intriguing avenue of inquiry that may yield insights into metabolic 
dysfunction in these cells. 
 
Longevity and quality control of modified proteins 
For decades, protein carbonylation has been described as a permanent 
modification to proteins that generally leads to damage, unfolding, aggregates 
and proteasomal degradation. Despite this, the mechanistic details of this 
process are still under debate142. The discovery of histones as a prominent target 
precipitated much thought surrounding these processes. It will be exciting to 
investigate whether or not histone carbonylation is reversible (either 
enzymatically or as a result of histone turnover). While still controversial, a recent 
study demonstrated enzymatically driven de-carbonylation of in-vitro modified 
substrates179. If it is verified that these enzymes exhibit de-carbonylase activity in 
vivo, it would have enormous implications in the field of redox biology, as it would 
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suggest that carbonylation is a signaling event rather than an end-point of 
oxidative damage. Furthermore, it would help to explain why we consistently see 
the modification of specific proteins rather than random global modification. 
These questions are particularly relevant in the field of obesity. For example, if 
histone modifications accumulate during obesity, will exercise and diet 
interventions reverse this effect? This type of experiment can readily be carried 
out with mouse models. In addition, it will be necessary to perform careful 
evaluation of histone turnover, as it is unclear what the half-life of histone 
proteins is in a terminally differentiated adipocyte. 
 
4-HNE and 4-HHE similarities and differences 
A common theme in much of the work described here is that 4-HNE and 4-HHE 
modify different proteins. These two lipids are chemically very similar and it is 
unclear how a chemically driven process would result in the observed selectivity. 
The proteomic evaluation of nuclear targets did suggest differences in the 
chemical microenvironment for the two modifications, but there are many 
questions that remain. Moving forward study of the mechanisms, whether 
chemical or potentially enzymatic, that drive these differences will be important. 
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Antioxidant expression in obese adipose tissue 
A number of studies from our lab and others indicate that metabolic disease is 
coincident with elevated oxidative stress in metabolic tissues such as liver, brain, 
skeletal muscle, cardiac muscle, pancreas, and adipose tissue102,143. Normally, 
acute oxidative stress leads to activation of transcription factor Nrf2, which 
subsequently stimulates expression of antioxidants to prevent and repair damage 
from various forms of ROS. However, in many pathological states and tissues, it 
is clear that metabolic disease coincides with transcriptional down regulation of 
antioxidant enzymes such as Gsta4, Gpx4, Prdx3, catalase, thioredoxins, and 
aldehyde dehydrogenases1,143. The decreased cellular antioxidant capacity is a 
major contributor to oxidative stress, though the mechanism by which it occurs is 
not well understood. Moreover, the unattenuated production of ROS leads to a 
futile loop in which the ROS damages cellular machinery, particularly in the 
mitochondrion, which leads to more ROS production. As such, the antioxidants 
sit at a critical nexus in cellular metabolism and understanding how they are 
transcriptionally regulated is an important and relevant course of study.  
 
In summary, the work described herein was designed and carried out to 
investigate the link between oxidative stress and metabolic dysfunction in 
adipose tissue. This led to several important discoveries on the role of protein 
carbonylation in the obese adipose tissue and has generated many new 
investigatory paths to pursue in the future. 
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